array:25 [
  "pii" => "S0211699519301602"
  "issn" => "02116995"
  "doi" => "10.1016/j.nefro.2019.08.001"
  "estado" => "S300"
  "fechaPublicacion" => "2020-03-01"
  "aid" => "658"
  "copyright" => "Sociedad Española de Nefrología"
  "copyrightAnyo" => "2019"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2020;40:171-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 253
    "formatos" => array:3 [
      "EPUB" => 47
      "HTML" => 138
      "PDF" => 68
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:20 [
      "pii" => "S2013251420300432"
      "issn" => "20132514"
      "doi" => "10.1016/j.nefroe.2020.03.012"
      "estado" => "S300"
      "fechaPublicacion" => "2020-03-01"
      "aid" => "658"
      "copyright" => "Sociedad Española de Nefrología"
      "documento" => "article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia (English Version). 2020;40:171-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
        "titulo" => "Paricalcitol regulatory effect on inflammatory&#44; fibrotic and anticalcificating parameters in renal patient&#46; Far beyond mineral bone disease regulation"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "es"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "171"
            "paginaFinal" => "179"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Efecto regulador de paricalcitol sobre par&#225;metros inflamatorios&#44; fibr&#243;ticos y anticalcificantes en el paciente con enfermedad renal cr&#243;nica&#46; M&#225;s all&#225; de la regulaci&#243;n de la enfermedad &#243;seo-mineral"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Fig&#46; 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 2866
                "Ancho" => 1485
                "Tamanyo" => 148966
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">&#40;A and B&#41; Changes in parameters of CKD-MBD &#40;Klotho and FGF-23&#41; throughout the study&#46; &#40;C&#8211;H&#41; Changes in parameters related to inflammation&#44; fibrosis and vascular calcification throughout the study&#46; Values expressed as arithmetic means&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Laura Salanova Villanueva, Yohana Gil Giraldo, Bego&#241;a Santos S&#225;nchez-Rey, Abelardo Aguilera Peralta"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "Laura"
                "apellidos" => "Salanova Villanueva"
              ]
              1 => array:2 [
                "nombre" => "Yohana"
                "apellidos" => "Gil Giraldo"
              ]
              2 => array:2 [
                "nombre" => "Bego&#241;a"
                "apellidos" => "Santos S&#225;nchez-Rey"
              ]
              3 => array:2 [
                "nombre" => "Abelardo"
                "apellidos" => "Aguilera Peralta"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0211699519301602"
          "doi" => "10.1016/j.nefro.2019.08.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699519301602?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420300432?idApp=UINPBA000064"
      "url" => "/20132514/0000004000000002/v1_202005210712/S2013251420300432/v1_202005210712/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S0211699519301730"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2019.07.005"
    "estado" => "S300"
    "fechaPublicacion" => "2020-03-01"
    "aid" => "659"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2020;40:180-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 822
      "formatos" => array:3 [
        "EPUB" => 64
        "HTML" => 433
        "PDF" => 325
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "&#191;Cu&#225;ndo realizar biopsia renal en pacientes con diabetes mellitus tipo<span class="elsevierStyleHsp" style=""></span>2&#63; Modelo predictivo de enfermedad renal no diab&#233;tica"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "180"
          "paginaFinal" => "189"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "When to perform renal biopsy in patients with type<span class="elsevierStyleHsp" style=""></span>2 diabetes mellitus&#63; Predictive model of non-diabetic renal disease"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figura 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1082
              "Ancho" => 2220
              "Tamanyo" => 143019
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">N&#250;mero de pacientes con nefropat&#237;a diab&#233;tica &#40;ND&#41; y enfermedad renal no diab&#233;tica &#40;ERND&#41; seg&#250;n puntuaci&#243;n del <span class="elsevierStyleItalic">score</span>&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Florencio Garc&#237;a-Mart&#237;n, Esther Gonz&#225;lez Monte, Eduardo Hern&#225;ndez Mart&#237;nez, Teresa Bada Boch, Norman E&#46; Bustamante Jim&#233;nez, Manuel Praga Terente"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Florencio"
              "apellidos" => "Garc&#237;a-Mart&#237;n"
            ]
            1 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "Gonz&#225;lez Monte"
            ]
            2 => array:2 [
              "nombre" => "Eduardo"
              "apellidos" => "Hern&#225;ndez Mart&#237;nez"
            ]
            3 => array:2 [
              "nombre" => "Teresa"
              "apellidos" => "Bada Boch"
            ]
            4 => array:2 [
              "nombre" => "Norman E&#46;"
              "apellidos" => "Bustamante Jim&#233;nez"
            ]
            5 => array:2 [
              "nombre" => "Manuel"
              "apellidos" => "Praga Terente"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2013251420300444"
        "doi" => "10.1016/j.nefroe.2020.03.013"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420300444?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699519301730?idApp=UINPBA000064"
    "url" => "/02116995/0000004000000002/v1_202002280639/S0211699519301730/v1_202002280639/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0211699519301547"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2019.06.008"
    "estado" => "S300"
    "fechaPublicacion" => "2020-03-01"
    "aid" => "652"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2020;40:160-70"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 263
      "formatos" => array:3 [
        "EPUB" => 45
        "HTML" => 140
        "PDF" => 78
      ]
    ]
    "es" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Inflexibilidad psicol&#243;gica e impacto cl&#237;nico&#58; adaptaci&#243;n del Cuestionario de Aceptaci&#243;n y Acci&#243;n-II en una muestra de pacientes en tratamiento de hemodi&#225;lisis"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "160"
          "paginaFinal" => "170"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Psychological inflexibility and clinical impact&#58; Adaptation of the acceptance and action questionnaire-II in a sample of patients on haemodialysis treatment"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Carlos J&#46; Delgado Dom&#237;nguez, Javier Varas Garc&#237;a, Francisco J&#46; Ruiz, Beatriz D&#237;az Espejo, Petra Cant&#243;n Guerrero, Elena Ruiz S&#225;nchez, Noelia Gonz&#225;lez Jurado, Abraham Rinc&#243;n Bello, Rosa Ramos S&#225;nchez"
          "autores" => array:9 [
            0 => array:2 [
              "nombre" => "Carlos J&#46;"
              "apellidos" => "Delgado Dom&#237;nguez"
            ]
            1 => array:2 [
              "nombre" => "Javier"
              "apellidos" => "Varas Garc&#237;a"
            ]
            2 => array:2 [
              "nombre" => "Francisco J&#46;"
              "apellidos" => "Ruiz"
            ]
            3 => array:2 [
              "nombre" => "Beatriz"
              "apellidos" => "D&#237;az Espejo"
            ]
            4 => array:2 [
              "nombre" => "Petra"
              "apellidos" => "Cant&#243;n Guerrero"
            ]
            5 => array:2 [
              "nombre" => "Elena"
              "apellidos" => "Ruiz S&#225;nchez"
            ]
            6 => array:2 [
              "nombre" => "Noelia"
              "apellidos" => "Gonz&#225;lez Jurado"
            ]
            7 => array:2 [
              "nombre" => "Abraham"
              "apellidos" => "Rinc&#243;n Bello"
            ]
            8 => array:2 [
              "nombre" => "Rosa"
              "apellidos" => "Ramos S&#225;nchez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2013251420300390"
        "doi" => "10.1016/j.nefroe.2019.06.006"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420300390?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699519301547?idApp=UINPBA000064"
    "url" => "/02116995/0000004000000002/v1_202002280639/S0211699519301547/v1_202002280639/es/main.assets"
  ]
  "es" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
    "titulo" => "Efecto regulador de paricalcitol sobre par&#225;metros inflamatorios&#44; fibr&#243;ticos y anticalcificantes en el paciente con enfermedad renal cr&#243;nica&#46; M&#225;s all&#225; de la regulaci&#243;n de la enfermedad &#243;seo-mineral"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "171"
        "paginaFinal" => "179"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Laura Salanova Villanueva, Yohana Gil Giraldo, Bego&#241;a Santos S&#225;nchez-Rey, Abelardo Aguilera Peralta"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "Laura"
            "apellidos" => "Salanova Villanueva"
            "email" => array:1 [
              0 => "aelita.sv@gmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Yohana"
            "apellidos" => "Gil Giraldo"
          ]
          2 => array:2 [
            "nombre" => "Bego&#241;a"
            "apellidos" => "Santos S&#225;nchez-Rey"
          ]
          3 => array:2 [
            "nombre" => "Abelardo"
            "apellidos" => "Aguilera Peralta"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Nefrolog&#237;a&#44; Hospital Universitario de la Princesa&#44; Madrid&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Paricalcitol regulatory effect on inflammatory&#44; fibrotic and anticalcificating parameters in renal patiente&#46; Far beyond mineral bone disease regulation"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1426
            "Ancho" => 2091
            "Tamanyo" => 250652
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Esquema de investigaci&#243;n cl&#237;nica&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Introducci&#243;n</span><p id="par0005" class="elsevierStylePara elsevierViewall">La enfermedad &#243;seo-mineral &#40;EOM&#41; relacionada con la enfermedad renal cr&#243;nica &#40;ERC&#41; &#8211;EOM-ERC&#8211; conlleva alteraciones bioqu&#237;micas como aumento de calcio &#40;Ca&#41;&#44; f&#243;sforo &#40;P&#41;&#44; hormona paratiroidea &#40;PTH&#41;&#44; calcitriol&#44; factor de crecimiento fibrobl&#225;stico 23 &#40;FGF-23&#41; y descenso de Klotho<a class="elsevierStyleCrossRefs" href="#bib0265"><span class="elsevierStyleSup">1&#44;2</span></a>&#59; estas alteraciones contribuyen a la calcificaci&#243;n vascular de distintas maneras&#58; la hiperfosfatemia&#44; el descenso de Klotho y de vitamina D activa&#44; y el aumento de FGF-23 promueven la entrada de P por los canales Pit1&#47;2 en las c&#233;lulas vasculares del m&#250;sculo liso con su consiguiente trasformaci&#243;n osteog&#233;nica<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">3&#8211;5</span></a>&#46; Otros factores que influyen en el desarrollo de la calcificaci&#243;n vascular en la ERC ser&#237;an la alteraci&#243;n de par&#225;metros relacionados con la inflamaci&#243;n y la fibrosis&#44; como el descenso de fetu&#237;na A &#40;Ft-A&#41; y de la prote&#237;na morfog&#233;nica &#243;sea 7 &#40;BMP-7&#41; o el aumento del factor de necrosis tumoral &#945; &#40;TNF-&#945;&#41; y del factor de crecimiento transformante &#946; &#40;TGF-&#946;&#41;<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">3-9</span></a>&#46; Este ambiente procalcificante del paciente con ERC justifica su alto riesgo cardiovascular<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">3</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Calcitriol y los an&#225;logos para el receptor de vitamina D &#40;AVDR&#41;&#44; como paricalcitol &#40;PRCT&#41;&#44; adem&#225;s de regular los niveles de PTH&#44; Ca o P&#44; presentan efectos pleiotr&#243;picos a nivel sist&#233;mico<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">8</span></a>&#59; uno de ellos es la protecci&#243;n endotelial<a class="elsevierStyleCrossRefs" href="#bib0305"><span class="elsevierStyleSup">9&#44;10</span></a>&#46; Distintos estudios han demostrado que calcitriol y AVDR protegen al endotelio de la calcificaci&#243;n al inhibir prote&#237;nas calcificantes como <span class="elsevierStyleItalic">matrix</span> gla prote&#237;na y reduciendo citoquinas proinflamatorias<a class="elsevierStyleCrossRefs" href="#bib0315"><span class="elsevierStyleSup">11&#44;12</span></a>&#46; No obstante el efecto de calcitriol podr&#237;a diferir al de PRCT<a class="elsevierStyleCrossRefs" href="#bib0325"><span class="elsevierStyleSup">13&#44;14</span></a>&#59; calcitriol&#44; a nivel vascular&#44; podr&#237;a tener dos consecuencias antag&#243;nicas</p><p id="par0015" class="elsevierStylePara elsevierViewall">dosis-dependiente&#58; a dosis hipercalcemiantes calcitriol presenta un efecto procalcificante sobre la CMLV mediado en parte por las acciones del P y mol&#233;culas procalcificantes a nivel celular&#59; PRCT no parece presentar esa dualidad</p><p id="par0020" class="elsevierStylePara elsevierViewall">dosis-dependiente<a class="elsevierStyleCrossRefs" href="#bib0325"><span class="elsevierStyleSup">13&#44;14</span></a>&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Por esta raz&#243;n estudiamos el efecto de PRCT sobre la EOM-ERC y mol&#233;culas asociadas a calcificaci&#243;n vascular&#44; inflamaci&#243;n y fibrosis en pacientes con ERC &#40;estadios III-V sin di&#225;lisis&#41; en b&#250;squeda de un efecto modulador sobre los mismos&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Material y m&#233;todos</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Pacientes</span><p id="par0030" class="elsevierStylePara elsevierViewall">Se trata de un estudio prospectivo no controlado realizado en el Hospital Universitario de La Princesa &#40;Madrid&#41;&#46; Preseleccionamos a 59 pacientes estadio III-V sin di&#225;lisis&#44; mayores de edad susceptibles de utilizar PRCT por aumento de PTH seg&#250;n estadificaci&#243;n de su ERC<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">1</span></a>&#58; estadio III<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>70 pg&#47;mL&#44; IV<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>110 pg&#47;mL&#44; estadio V<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>150 pg&#47;mL &#40;Gu&#237;as SEN&#41;&#46; Los criterios de exclusi&#243;n fueron&#58; inclusi&#243;n en terapia sustitutiva renal&#44; fallo card&#237;aco y&#47;o hep&#225;tico agudo&#44; enfermedad infecciosa o inmunol&#243;gica activa y alergia a PRCT &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; Finalmente seleccionamos a 46 pacientes con un seguimiento de cuatro meses en tratamiento con PRCT&#58; 1mcg diario si PTH<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>500 pg&#47;mL y 2 mcg diario si PTH<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>500 pg&#47;mL&#46; Ning&#250;n paciente super&#243; los 500 pg&#47;mL de PTH&#46; Las dosis de PRCT se suspender&#237;an si PTH<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>70 pg&#47;mL&#46; Siete pacientes ten&#237;an prescrito calcidiol&#59; no hubo otros tratamientos relacionados con vitamina D o an&#225;logos&#44; por lo que se realiz&#243; periodo de lavado de un mes previo al inicio del estudio&#46; No hubo p&#233;rdidas de pacientes en el seguimiento durante estos cuatro meses&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Determinaciones</span><p id="par0035" class="elsevierStylePara elsevierViewall">Se realizaron determinaciones anal&#237;ticas sangu&#237;neas y urinarias en el momento basal&#44; al mes y a los cuatro meses de iniciado PRCT&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Las muestras sangu&#237;neas de los test espec&#237;ficos se centrifugaron a 1200 revoluciones por minuto durante 10 minutos&#44; se extrajo el suero&#44; se alicuot&#243; y almacen&#243; a -80<span class="elsevierStyleHsp" style=""></span>&#176;C para su posterior an&#225;lisis&#46; Las determinaciones de ELISA fueron efectuadas de acuerdo al protocolo descrito por el fabricante&#46; Las concentraciones de los par&#225;metros se determinaron por la curva est&#225;ndar y respectivas diluciones&#46; Los par&#225;metros bioqu&#237;micos valorados en cada una de las visitas fueron&#58; creatinina &#40;Cr&#41;&#44; MDRD 4 tasa de filtrado glomerular &#40;TFG&#41;&#44; proteinuria mg&#47;24<span class="elsevierStyleHsp" style=""></span>h&#44; Ca&#44; Pi&#44; calcidiol &#40;Roche&#47;Hitachi Cobas&#41;&#44; PTHi &#40;Roche&#47;Hitachi Cobas&#174;&#58; fragmentos 1-84&#41;&#44; fracci&#243;n soluble Klotho &#40;ELISA Cusabio&#174;&#44; 7&#44;8-500 pg&#47;mL&#41;&#44; iFGF-23 &#40;Millipore&#174;&#59; 9&#44;9-2400 pg&#47;mL&#41;&#46; Par&#225;metros relacionados con la inflamaci&#243;n&#58; interleucina &#40;IL&#41; 6 &#40;R &#38; D&#174;&#44; HS600B&#59; 0&#44;156-10 pg&#47;mL&#41;&#44; TNF<span class="elsevierStyleHsp" style=""></span>&#8722;<span class="elsevierStyleHsp" style=""></span>&#945; &#40;ELISA R &#38; D&#44; HSTA00D&#59; 0&#44;52-32 pg&#47;mL&#41;&#44; IL10 &#40;R &#38; D&#44; 0&#44;78-50 pg&#47;mL&#41;&#44; prote&#237;na C reactiva &#40;PCR&#41; &#40;Roche&#47;Hitachi Cobas&#41; &#174;&#46; Par&#225;metros relacionados con calcificaci&#243;n y fibrosis&#58; Ft-A &#40;Bio Vendor&#59; 0&#44;698-2&#46;330<span class="elsevierStyleHsp" style=""></span>g&#47;L&#41;&#44; BMP-7 &#40;R &#38; D&#59; 31&#46;20-2000 pg&#47;mL&#41; &#174;&#44; TGF-&#946;1 &#40;R &#38; D systems Quantikine ELISA&#174;&#59; 31&#46;20-2000 pg&#47;mL&#41;&#8901;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">An&#225;lisis estad&#237;stico</span><p id="par0045" class="elsevierStylePara elsevierViewall">Realizamos un estudio anal&#237;tico prospectivo no controlado antes-despu&#233;s&#46; Las variables recogidas fueron analizadas por el programa estad&#237;stico SPSS-21&#46; El an&#225;lisis se hizo considerando las tres evaluaciones bioqu&#237;micas de los pacientes &#40;basal&#44; uno y cuatro meses&#41;&#46; Las variables dimensionales se muestran como promedio<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>desviaci&#243;n est&#225;ndar &#40;DE&#41;&#46; Las variables nominales se muestran como n&#250;meros o porcentajes&#46; Las diferencias intragrupo fueron analizadas mediante <span class="elsevierStyleItalic">ANOVA</span> one way para muestras repetidas<span class="elsevierStyleItalic">&#46;</span> Se consider&#243; como resultado significativo un valor p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Medidas de seguridad y consideraciones &#233;ticas</span><p id="par0050" class="elsevierStylePara elsevierViewall">El presente estudio es considerado categor&#237;a II&#44; con riesgo m&#237;nimo&#46; En cada visita se indag&#243; sobre la presencia de eventos adversos tomando las medidas oportunas&#46; Se obtuvo consentimiento informado por parte de los pacientes<span class="elsevierStyleItalic">&#46;</span> La recogida de datos se realiz&#243; respetando la confidencialidad del paciente seg&#250;n la Ley de Protecci&#243;n de Datos de Car&#225;cter Personal y se respetaron los aspectos &#233;ticos de la investigaci&#243;n en seres humanos en Espa&#241;a&#46;</p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Resultados</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Descripci&#243;n de la cohorte</span><p id="par0055" class="elsevierStylePara elsevierViewall">Seleccionamos 46 pacientes&#58; 38 hombres &#40;82&#37;&#41; y 8 &#40;18&#37;&#41; mujeres&#44; con una edad media de 73 a&#241;os&#46; Los porcentajes seg&#250;n estadificaci&#243;n de ERC y etiolog&#237;a se muestran en la <a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#46; En cuanto a los tratamientos farmacol&#243;gicos 7 pacientes &#40;15&#37;&#41; tomaban previamente calcidiol &#40;periodo de lavado durante un mes previo al inicio del estudio&#41;&#44; 6 pacientes &#40;13&#37;&#41; estaban en tratamiento con captores del f&#243;sforo y 33 pacientes &#40;71&#44;8&#37;&#41; ten&#237;an prescrito inhibidores del sistema renina angiotensina aldosterona &#40;SRAA&#41;&#46; Ninguno de ellos presentaba tratamiento concomitante con cinacalcet&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Efecto de paricalcitol sobre las variables bioqu&#237;micas generales&#44; tasa de filtrado glomerular y proteinuria</span><p id="par0060" class="elsevierStylePara elsevierViewall">Los cambios experimentados&#44; tras la administraci&#243;n de PRCT&#44; sobre las variables hemoglobina&#44; hierro&#44; saturaci&#243;n de trasferrina&#44; CO2 total&#44; alb&#250;mina&#44; prealb&#250;mina&#44; perfil hep&#225;tico y lip&#237;dico no mostraron cambios significativos&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">La proteinuria no vari&#243; significativamente &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;299&#41;&#59; tampoco se produjo descenso significativo &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;766&#41; entre los pacientes que no presentaban tratamiento con inhibidores del SRAA &#40;28&#44;2&#37;&#41;&#46; S&#237; se produjo un aumento de creatinina significativo &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;007&#41; y cercano a la significaci&#243;n estad&#237;stica en la TFG &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;053&#41;&#59; ante estos datos subdividimos a los pacientes seg&#250;n grado de ERC catalog&#225;ndola como grave si TFG<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>ml&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span> &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>25&#41; o moderada si TFG<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>ml&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span> &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>21&#41;&#46; En los pacientes con ERC grave se produjo un descenso significativo de la TFG &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;002&#41;&#59; sin embargo&#44; entre los pacientes con ERC moderada&#44; no hubo significaci&#243;n estad&#237;stica &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;652&#41;&#46; Estos datos los mostramos en la <a class="elsevierStyleCrossRef" href="#tbl0010">tabla 2</a>&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Efecto de PRCT sobre la EOM-ERC</span><p id="par0070" class="elsevierStylePara elsevierViewall">Los marcadores cl&#225;sicos de la EOM-ERC como Ca y P no se vieron modificados &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;112&#44; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;066 respectivamente&#41;&#46; No hubo aumentos de Ca por encima<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>10&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dL ni de P<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>5&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dL&#44; por lo que no hubo que modificar la pauta de captores del P ni dosis de PRCT&#46; S&#237; se observ&#243; un descenso significativo de PTHi &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;02&#41;&#59; no obstante&#44; los valores de PTHi se mantuvieron en rango seg&#250;n estadificaci&#243;n en todos los pacientes &#40;Gu&#237;as SEN&#41; por lo que no hubo que suspender PRCT en ning&#250;n paciente&#46; Tambi&#233;n observamos un aumento de calcidiol significativo &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;010&#41;&#46; Datos desglosados en la <a class="elsevierStyleCrossRef" href="#tbl0015">tabla 3</a>&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">En cuanto a los par&#225;metros m&#225;s novedosos de la EOM-ERC &#40;<a class="elsevierStyleCrossRef" href="#fig0010">fig&#46; 2</a>&#41;&#44; iFGF-23 no se modific&#243; significativamente a lo largo del estudio &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;577&#41;&#59; tampoco entre los pacientes en tratamiento con captores del P &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>6&#59; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;125&#41;&#46; Calculamos la diferencia de medias al finalizar el estudio &#40;t de Student para muestras independientes&#41; entre pacientes con o sin captores del P&#44; el resultado no alcanz&#243; la significaci&#243;n estad&#237;stica &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;953&#44; con una diferencia de medias de 2&#44;48&#41;&#46; Se produjo un aumento significativo de los niveles de Klotho &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Efectos de PRCT sobre par&#225;metros relacionados con inflamaci&#243;n&#44; fibrosis y calcificaci&#243;n vascular</span><p id="par0080" class="elsevierStylePara elsevierViewall">No apreciamos cambios estad&#237;sticamente significativos en los niveles de PCR&#44; aunque la tendencia fue descendente&#46; IL6 y TNF-&#945; descendieron de forma significativa tras el uso de PRCT&#58; IL6 &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y TNF-&#945; &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;005&#41;&#46; IL10&#44; par&#225;metro antiinflamatorio&#44; aument&#243; significativamente &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46; En cuanto a par&#225;metros relacionados con la fibrosis y calcificaci&#243;n vascular&#44; observamos aumento significativo de Ft-A &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y BMP-7 &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y descenso de TGF-&#946;1 &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46; Datos mostrados en la <a class="elsevierStyleCrossRef" href="#tbl0020">tabla 4</a> y <a class="elsevierStyleCrossRef" href="#fig0010">figura 2</a>&#46;</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Efectos adversos</span><p id="par0085" class="elsevierStylePara elsevierViewall">Durante el estudio no se produjeron reacciones adversas al medicamento&#44; ni cambios en el tratamiento&#46; No se produjeron ingresos ni eventos cardiovasculares&#46;</p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Discusi&#243;n</span><p id="par0090" class="elsevierStylePara elsevierViewall">En nuestro estudio los pacientes presentaban una mejor&#237;a de par&#225;metros relacionados con los procesos inflamatorio&#44; fibr&#243;tico y de calcificaci&#243;n vascular&#46; El impacto sobre marcadores de EOM-ERC muestran estabilidad en variables como Ca&#44; P&#44; FGF-23 y mejor&#237;a en otros como Klotho o PTH&#46; La EOM-ERC y la inflamaci&#243;n son determinantes en el inicio y la progresi&#243;n de la ERC y del RCV en estos enfermos<a class="elsevierStyleCrossRefs" href="#bib0335"><span class="elsevierStyleSup">15&#44;16</span></a>&#46; PRCT ha demostrado&#44; en m&#250;ltiples estudios experimentales&#44; su perfil seguro y beneficioso para regular la EOM-ERC y marcadores inflamatorios en la ERC sin agravar el proceso renal<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">17&#44;18</span></a>&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">En diferentes estudios se ha evaluado el efecto sobre la funci&#243;n renal y proteinuria de PRCT&#46; El estudio VITAL<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">19</span></a> demostr&#243;&#44; en pacientes diab&#233;ticos tipo 2&#44; una reducci&#243;n de proteinuria significativa a dosis de 2 ug&#47;d&#237;a de PRCT&#46; Similares resultados mostr&#243; el estudio de Agarwal et al&#46;<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">20</span></a> en pacientes con ERC EIII-IV&#46; El efecto antiprotein&#250;rico de PRCT&#44; y vitamina D activa&#44; tiene relaci&#243;n con la regulaci&#243;n del proceso proliferativo y fibr&#243;tico<a class="elsevierStyleCrossRefs" href="#bib0365"><span class="elsevierStyleSup">21&#44;22</span></a> y bloqueo del SRAA<a class="elsevierStyleCrossRefs" href="#bib0355"><span class="elsevierStyleSup">19&#44;23</span></a>&#59; la inhibici&#243;n farmacol&#243;gica de este eje puede condicionar que haya que aumentar la dosis de PRCT para conseguir el descenso de proteinuria&#46; En nuestro estudio no obtuvimos diferencias significativas en la evoluci&#243;n de la proteinuria&#44; tal vez debido al amplio uso de los inhibidores del SRAA &#40;71&#44;8&#37;&#41;&#46; En cuanto a la TFG&#44; no obtuvimos datos estad&#237;sticos significativos aunque s&#237; una tendencia al descenso tal vez debido al deterioro significativo que mostraban los enfermos con TFG<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>ml&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span>&#46; En cuanto al aumento significativo de Cr podr&#237;a estar en relaci&#243;n a la influencia de variables externas como sexo&#44; edad&#44; masa muscular y estado nutricional sobre esta variable&#46; Podr&#237;amos concluir que la activaci&#243;n del receptor de vitamina D con PRCT mantiene la TFG estable&#44; coincidiendo con otros estudios<a class="elsevierStyleCrossRefs" href="#bib0380"><span class="elsevierStyleSup">24&#44;25</span></a>&#46; Este efecto de PRCT podr&#237;a conllevar la atenuaci&#243;n sobre el da&#241;o glomerular&#44; tubulointersticial y endotelial que ha demostrado en ensayos experimentales mediante efectos antiinflamatorios<a class="elsevierStyleCrossRefs" href="#bib0390"><span class="elsevierStyleSup">26&#44;27</span></a>&#44; antifibr&#243;ticos<a class="elsevierStyleCrossRef" href="#bib0400"><span class="elsevierStyleSup">28</span></a> y antiprotein&#250;ricos<a class="elsevierStyleCrossRefs" href="#bib0355"><span class="elsevierStyleSup">19&#44;20</span></a> como comentaremos a posteriori&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">Como era de esperar&#44; PRCT redujo PTHi de manera significativa coincidiendo con diversos estudios<a class="elsevierStyleCrossRefs" href="#bib0405"><span class="elsevierStyleSup">29&#44;30</span></a>&#46; Evidenciamos estabilidad en los niveles de Ca y P&#44; aunque en el caso del P la tendencia era al alza&#46; Este efecto menos hipercalcemiante e hiperfosfatemiante de PRCT viene determinado al producirse menos calbindina intestinal y a su menor afinidad por los receptores intestinales de vitamina D<a class="elsevierStyleCrossRef" href="#bib0415"><span class="elsevierStyleSup">31</span></a>&#44; lo cual podr&#237;a influir en la g&#233;nesis de la calcificaci&#243;n vascular&#46; No hay un claro mecanismo del aumento de calcidiol en nuestro estudio&#59; tal vez sea debido a la estabilidad de FGF-23 &#40;estimulante de la 24-hidroxilasa que inactiva calcidiol&#41; que obtuvimos&#46; En este sentido&#44; y siguiendo en el marco de la EOM&#44; el efecto de PRCT sobre marcadores como FGF-23 y Klotho ser&#237;a relevante dado que ambos par&#225;metros podr&#237;an modular la calcificaci&#243;n vascular&#44; el estado inflamatorio y la funci&#243;n renal&#46; En el caso de Klotho obtuvimos un aumento significativo de sus niveles s&#233;ricos&#59; Klotho posee efectos beneficiosos a nivel mioc&#225;rdico y la hipertrofia ventricular izquierda<a class="elsevierStyleCrossRefs" href="#bib0425"><span class="elsevierStyleSup">33&#44;34</span></a>&#44; antiinflamatorios<a class="elsevierStyleCrossRefs" href="#bib0420"><span class="elsevierStyleSup">32&#44;36</span></a> &#40;descenso de los niveles de IL6 y 18&#41;&#44; antifibr&#243;ticos<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">35</span></a> &#40;descenso de TGF-&#946;&#41; y efectos antiapoptoicos<a class="elsevierStyleCrossRef" href="#bib0445"><span class="elsevierStyleSup">37</span></a> que podr&#237;an influir en la g&#233;nesis de la calcificaci&#243;n vascular<a class="elsevierStyleCrossRefs" href="#bib0420"><span class="elsevierStyleSup">32&#44;36</span></a>&#46; PRCT ha demostrado regular al alza los niveles de Klotho en diversos estudios como el de Lau et al&#46;<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">11</span></a> donde el tratamiento de PRCT y calcitriol&#44; en ratones ur&#233;micos con calcificaci&#243;n vascular&#44; aument&#243; de forma significativa los niveles de Klotho urinarios y s&#233;ricos&#46; En lo referente a los niveles FGF-23 nuestro estudio mostr&#243; resultados dispares frente a otros como el IMPACT<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">38</span></a> o PARADIGM<a class="elsevierStyleCrossRef" href="#bib0455"><span class="elsevierStyleSup">39</span></a> donde el uso de PRCT o calcitriol&#44; en pacientes en hemodi&#225;lisis&#44; aumentaba FGF-23&#46; Esta discordancia podr&#237;a ser debida a que nuestros pacientes no estaban incluidos en di&#225;lisis y se les presupone mayor funci&#243;n renal residual&#46; No hay duda de que el aumento de FGF-23 en la ERC se relaciona con la calcificaci&#243;n vascular&#44; aunque no como inductor<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">40</span></a>&#44; y con un aumento en la morbimortalidad vascular<a class="elsevierStyleCrossRefs" href="#bib0465"><span class="elsevierStyleSup">41&#8211;43</span></a>&#46; FGF-23 suprime los niveles de calcitriol<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">3&#44;6</span></a> y de Ft-A<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">41</span></a> &#40;potente anticalcificante&#41;&#44; provoca disfunci&#243;n endotelial&#44; desarrollo de hipertrofia ventricular izquierda y proteinuria<a class="elsevierStyleCrossRefs" href="#bib0465"><span class="elsevierStyleSup">41&#44;42</span></a>&#46; Muchos de estos mecanismos procalcificantes de FGF-23 tienen como agravante el ambiente inflamatorio de la ERC<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">3&#44;44</span></a> que es estimulado por FGF-23 induciendo el aumento de IL6 y TNF-&#945; <a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">45</span></a>&#46; A su vez&#44; el propio estado inflamatorio regula al alza los niveles de FGF-23&#58; TNF-&#945; y NF-&#954;B pueden inhibir la matriz &#243;sea y aumentar la producci&#243;n de FGF-23 en el osteocito<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">45</span></a>&#46; Adem&#225;s el estado proinflamatorio y fibr&#243;tico de la ERC modula los niveles de Klotho a la baja<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">36</span></a>&#46;</p><p id="par0105" class="elsevierStylePara elsevierViewall">La propia inflamaci&#243;n es un target terap&#233;utico en la ERC donde PRCT ha demostrado sus efectos beneficiosos<a class="elsevierStyleCrossRefs" href="#bib0325"><span class="elsevierStyleSup">13&#44;14</span></a>&#46; Tras el uso de PRCT nuestros pacientes presentaban un efecto bioqu&#237;mico antiinflamatorio favorable al descender de manera significativamente los niveles de IL6 y TNF-&#945; y aumentar IL10&#44; mediado tal vez por el aumento de Klotho y estabilidad de FGF-23 o por un efecto directo del f&#225;rmaco&#46; Donate et al&#46;<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">22</span></a> coinciden con nuestros resultados&#59; estos autores demostraron en pacientes con ERC y elevaci&#243;n de PTH &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>8&#59; estadiajes IIIB-IV&#41; que el tratamiento con PRCT provoc&#243; un descenso significativo de IL6 y TNF-&#945;&#46; El efecto antiinflamatorio de PRCT podr&#237;a estar condicionado por la disminuci&#243;n de la producci&#243;n de citoquinas por las c&#233;lulas T<a class="elsevierStyleCrossRefs" href="#bib0390"><span class="elsevierStyleSup">26&#44;27</span></a>&#46; Estos efectos antiinflamatorios de PRCT podr&#237;an influir sobre par&#225;metros anticalcificantes como Ft-A o BMP-7 &#40;descendidos en pacientes con ERC<a class="elsevierStyleCrossRefs" href="#bib0300"><span class="elsevierStyleSup">8&#44;46</span></a>&#41;&#44; y fibr&#243;ticos como TGF-&#946; &#40;aumentado en ERC&#41;&#46; El aumento de Ft-A tras el uso de PRCT que obtuvimos podr&#237;a mejorar el perfil procalcificante&#44; al igual que los resultados que obtuvimos sobre BMP-7 que&#44; adem&#225;s de sus efectos anticalcificantes<a class="elsevierStyleCrossRefs" href="#bib0495"><span class="elsevierStyleSup">47&#44;48</span></a> &#40;inhibe el cotransportador Na&#47;Pi de las CMLV&#41;&#44; promueve la formaci&#243;n &#243;sea y presenta efectos antiinflamatorios<a class="elsevierStyleCrossRefs" href="#bib0495"><span class="elsevierStyleSup">47&#44;49</span></a>&#46; El caso de TGF-&#946; es el contrario a BMP-7&#59; su descenso&#44; significativo en nuestro estudio&#44; podr&#237;a implicar nefroprotecci&#243;n y una atenuaci&#243;n del da&#241;o vascular<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">50</span></a> al disminuir la migraci&#243;n de stem cells mesenquimales osteoprogenitoras a las zonas da&#241;adas<a class="elsevierStyleCrossRef" href="#bib0515"><span class="elsevierStyleSup">51</span></a> promovida por TGF-&#946; y disminuyendo la apoptosis&#44; proliferaci&#243;n y diferenciaci&#243;n celular<a class="elsevierStyleCrossRef" href="#bib0520"><span class="elsevierStyleSup">52</span></a>&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">Nuestro estudio tiene limitaciones&#59; los pacientes son controles de s&#237; mismos&#44; no poseemos grupo placebo&#44; el tiempo de observaci&#243;n es corto y nuestra cohorte peque&#241;a lo cual puede conllevar alteraciones en la interpretaci&#243;n de resultados&#46; Adem&#225;s&#44; no diferenciamos los meses de inclusi&#243;n de los pacientes que podr&#237;a influir en los niveles de calcidiol al variar estacionalmente&#46; Basamos nuestros resultados en marcadores sangu&#237;neos y no en modelos experimentales de lesi&#243;n vascular&#59; as&#237; mismo no hemos aportado datos sobre otras mol&#233;culas como RANK-L &#40;ligando de r<span class="elsevierStyleItalic">eceptor</span>&#160;activador del factor nuclear &#954; beta&#41;&#44; osteopontina u osteoprotegerina&#46; Como contrapunto los par&#225;metros analizados abarcan una importante influencia en la calcificaci&#243;n vascular&#44; la inflamaci&#243;n y la fibrosis con una posible regulaci&#243;n favorable tras el tratamiento con PRCT&#46;</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Conclusiones</span><p id="par0115" class="elsevierStylePara elsevierViewall">El tratamiento con PRCT&#44; en el paciente renal sin di&#225;lisis&#44; parece ser beneficioso en la regulaci&#243;n de par&#225;metros inflamatorios&#44; fibr&#243;ticos y anticalcificantes&#59; as&#237; como sobre marcadores cl&#225;sicos y no cl&#225;sicos de la EOM-ERC preservando la funci&#243;n renal&#46; No existe un marcador que valore los efectos pleiotr&#243;picos de PRCT en la enfermedad renal&#46; Los marcadores elegidos en nuestro estudio podr&#237;an indicarnos su efecto en la enfermedad &#243;seo-mineral renal y&#44; en concreto&#44; en el proceso de calcificaci&#243;n vascular&#46;</p><p id="par0120" class="elsevierStylePara elsevierViewall">Los datos obtenidos podr&#237;an indicar un efecto modulador de PRCT positivos sobre marcadores relacionados con la calcificaci&#243;n vascular&#44; el estado inflamatorio y fibr&#243;tico de la ERC&#46;</p><p id="par0125" class="elsevierStylePara elsevierViewall">El abordaje terap&#233;utico de los AVDR sigue sin ser explorado en la cl&#237;nica de los pacientes con ERC&#44; quedando relegado como uso exclusivo en el hiperparatiroidismo secundario y sin la realizaci&#243;n de ensayos cl&#237;nicos con expectativas m&#225;s amplias en los &#250;ltimos a&#241;os en la pr&#225;ctica cl&#237;nica&#46; Esto deja un campo a&#250;n por explorar especialmente en lo que ata&#241;e a la calcificaci&#243;n vascular en pacientes con enfermedad renal cr&#243;nica&#46;</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Conflicto de intereses</span><p id="par0130" class="elsevierStylePara elsevierViewall">Los autores declaran no tener ning&#250;n conflicto de intereses&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:11 [
        0 => array:3 [
          "identificador" => "xres1312458"
          "titulo" => "Resumen"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Antecedentes"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Objetivos"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Material y m&#233;todos"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Resultados"
            ]
            4 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1211416"
          "titulo" => "Palabras clave"
        ]
        2 => array:3 [
          "identificador" => "xres1312457"
          "titulo" => "Abstract"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Backward"
            ]
            1 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Objective"
            ]
            2 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Material and methods"
            ]
            3 => array:2 [
              "identificador" => "abst0045"
              "titulo" => "Results"
            ]
            4 => array:2 [
              "identificador" => "abst0050"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1211415"
          "titulo" => "Keywords"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introducci&#243;n"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Material y m&#233;todos"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Pacientes"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Determinaciones"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "An&#225;lisis estad&#237;stico"
            ]
            3 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Medidas de seguridad y consideraciones &#233;ticas"
            ]
          ]
        ]
        6 => array:3 [
          "identificador" => "sec0035"
          "titulo" => "Resultados"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Descripci&#243;n de la cohorte"
            ]
            1 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Efecto de paricalcitol sobre las variables bioqu&#237;micas generales&#44; tasa de filtrado glomerular y proteinuria"
            ]
            2 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Efecto de PRCT sobre la EOM-ERC"
            ]
            3 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Efectos de PRCT sobre par&#225;metros relacionados con inflamaci&#243;n&#44; fibrosis y calcificaci&#243;n vascular"
            ]
            4 => array:2 [
              "identificador" => "sec0060"
              "titulo" => "Efectos adversos"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0065"
          "titulo" => "Discusi&#243;n"
        ]
        8 => array:2 [
          "identificador" => "sec0070"
          "titulo" => "Conclusiones"
        ]
        9 => array:2 [
          "identificador" => "sec0075"
          "titulo" => "Conflicto de intereses"
        ]
        10 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2019-02-16"
    "fechaAceptado" => "2019-08-23"
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1211416"
          "palabras" => array:6 [
            0 => "Paricalcitol"
            1 => "FGF-23"
            2 => "Klotho"
            3 => "Inflamaci&#243;n"
            4 => "Fetu&#237;na A"
            5 => "Estado ur&#233;mico&#46;"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1211415"
          "palabras" => array:6 [
            0 => "Paricalcitol"
            1 => "FGF-23"
            2 => "Klotho"
            3 => "Inflammation"
            4 => "Fetuin-A"
            5 => "Uremic status&#46;"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Antecedentes</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">La principal causa de morbimortalidad en el paciente con enfermedad renal cr&#243;nica &#40;ERC&#41; es la cardiovascular&#46; La inflamaci&#243;n y las alteraciones en el metabolismo &#243;seo-mineral en estos pacientes conllevan aumento del riesgo cardiovascular&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objetivos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Valorar el papel de paricalcitol sobre distintos par&#225;metros s&#233;ricos relacionados con inflamaci&#243;n&#44; fibrosis y enfermedad &#243;seo-mineral en la ERC&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Material y m&#233;todos</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Estudio prospectivo&#44; no controlado en 46 pacientes con ERC estadios III-V sin di&#225;lisis&#44; con niveles elevados de paratohormona&#44; seg&#250;n su estadio de ERC&#44; por lo que se introdujo tratamiento con el an&#225;logo de vitamina D paricalcitol&#46; Durante 4 meses de tratamiento valoramos los par&#225;metros cl&#225;sicos y novedosos del metabolismo &#243;seo-mineral en suero &#40;calcio&#44; f&#243;sforo&#44; paratohormona&#44; factor de crecimiento fibrobl&#225;stico-23 &#91;FGF-23&#93;&#44; Klotho y calcidiol&#41; y par&#225;metros relacionados con el proceso de inflamaci&#243;n-fibrosis y anticalcificantes &#40;interleucina-6 y 10&#44; factor de necrosis tumoral alfa &#91;TNF-a&#93;&#44; factor de crecimiento transformante beta &#91;TGF-b&#93;&#44; prote&#237;na &#243;sea morfog&#233;nica-7 &#91;BMP-7&#93;&#44; y fetu&#237;na-A&#41;&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Resultados</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Tras el uso de paricalcitol los niveles de Klotho aumentaron &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y los de FGF-23 se mantuvieron estables al igual que los de calcio y f&#243;sforo&#59; calcidiol aument&#243; de forma significativa &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;010&#41; y paratohormona descendi&#243; &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;002&#41;&#46; Los par&#225;metros de inflamaci&#243;n&#44; fibrosis y calcificaci&#243;n mostraron una regulaci&#243;n benigna con descenso significativo de interleucina-6 &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#44; TNF-&#945; &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;005&#41; y TGF-&#946; &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y aumento de BMP-7 &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#44; fetu&#237;na-A &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; e interleucina-10 &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46; El filtrado glomerular y la proteinuria se mantuvieron estables&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusiones</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">El tratamiento con paricalcitol en el paciente renal sin di&#225;lisis parece ser beneficioso en la regulaci&#243;n de los par&#225;metros inflamatorios y anticalcificantes&#44; preservando la funci&#243;n renal y el eje &#243;seo-mineral&#46; Los marcadores elegidos en nuestro estudio podr&#237;an indicarnos un efecto positivo de paricalcitol a nivel vascular&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Antecedentes"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Objetivos"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Material y m&#233;todos"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Resultados"
          ]
          4 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Backward</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Cardiovascular events are the major cause of morbidity and mortality in patients with chronic kidney disease &#40;CKD&#41;&#46; Inflammation and mineral-bone disorder are pathological conditions that have been associated with an increased cardiovascular risk&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objective</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Show paricalcitol regulation overinflammatory&#44; fibrotic and mineral disorder parameters in CKD&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Material and methods</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Prospective Study in 46 CKD stages III-V patients without dialysis patients whith elevated parathormone in which we introduced paricalcitol&#46; We evaluated classic and newest mineral and bone metabolism serum parameters &#40;calcium&#44; phosphorus&#44; parathormone&#44; fibroblast growth factor-23 &#91;FGF-23&#93;&#44; Klotho&#44; calcidiol&#41;&#44; inflammatory-fibrosis and anticalcifying parameters &#40;interleukin-6 and 10&#44; tumor necrosis factor-a &#91;TNF- &#945;&#93;&#44; transforming growth factor-b &#91;TGF-&#946;&#93;&#44;bone morphogenic protein-7 &#91;BMP-7&#93; and fetuin-A&#41; for four months&#46;</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Results</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">At the end of study soluble Klotho increased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41;&#44; FGF-23 remained stable&#44; calcium and phosphorus levels were not increased&#44; calcidiol increased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;010&#41; and PTH decreased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleMonospace">&#46;</span>002&#41;&#46; Inflammation-fibrosis and calcification parameters showed positive regulation after paricalcitol treatment&#58; interleukin-6 decreased significantly &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41; and also TNF-&#945; did &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;005&#41;&#44; on the contrary&#44; interleukin-10 and fetuin-A increased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001 for both&#41;&#46; Anti-fibrosis marker BMP-7 increased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41; and TGF-b decreased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41;&#46; We did not find significant changes in renal function&#46;</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusions</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Paricalcitol treatment might be profitable in regulating inflammatory and anticalcificant parameters&#44; unmodified calcium or phosphorus seric levels and preserving kidney function in renal patients with no dialysis&#46; Our selected parameters could indicate paricalcitol effects in mineral and endothelial disorder related to renal disease&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Backward"
          ]
          1 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Objective"
          ]
          2 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Material and methods"
          ]
          3 => array:2 [
            "identificador" => "abst0045"
            "titulo" => "Results"
          ]
          4 => array:2 [
            "identificador" => "abst0050"
            "titulo" => "Conclusions"
          ]
        ]
      ]
    ]
    "multimedia" => array:6 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1426
            "Ancho" => 2091
            "Tamanyo" => 250652
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Esquema de investigaci&#243;n cl&#237;nica&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 2889
            "Ancho" => 1488
            "Tamanyo" => 151311
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">A y B&#41; Evoluci&#243;n de los par&#225;metros m&#225;s novedosos de EOM-ERC &#40;Klotho y FGF-23&#41; a lo largo del estudio&#46;C-H&#41; Evoluci&#243;n de los par&#225;metros relacionados con inflamaci&#243;n&#44; fibrosis y calcificaci&#243;n vascular a lo largo del estudio&#46; Valores expresados en medias aritm&#233;ticas&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Los porcentajes en cada estadificaci&#243;n se refieren al n&#250;mero de enfermos en cada uno de ellos&#46;</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">AEE&#58; agente estimulante de la eritropoyesis&#59; DM&#58; diabetes mellitus&#59; GNII&#58; glomerulonefritis&#59; NAE&#58; nefroangioesclerosis&#59; SRAA&#58; sistema renina angiotensina aldosterona&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ERC Estadio III&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ERC Estadio IV&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ERC Estadio V&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">N&#46;&#176; Pacientes</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">46 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19 &#40;41&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23 &#40;50&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4 &#40;8&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="5" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="5" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Etiolog&#237;a</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>DM&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">18 &#40;39&#44;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7 &#40;36&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8 &#40;34&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;75&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>NAE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23 &#40;50&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10 &#40;52&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12 &#40;52&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;25&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>GNII&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5 &#40;11&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;10&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="5" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="5" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">F&#225;rmacos</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Captores del f&#243;sforo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6 &#40;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;5&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;50&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>SRAA inhibidores&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">33 &#40;71&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">14 &#40;73&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">16 &#40;69&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;75&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>AEE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">11 &#40;24&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;5&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8 &#40;34&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;50&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Calcidiol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7 &#40;15&#44;21&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;10&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4 &#40;17&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;25&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2249488.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas etiol&#243;gicas y farmacol&#243;gicas de los pacientes incluidos en el estudio seg&#250;n grado de ERC al inicio del estudio</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Tabla 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Funci&#243;n renal y proteinuria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rango normal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media basal<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 1 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 4 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">p valor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Creatinina &#40;mg&#47;dL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;5-1&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#44;54<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;05&#40;1&#44;3-6&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#44;56<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;08&#40;1&#44;2-6&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#44;69<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;18&#40;1&#44;1-7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;007</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TFG MDRD 4 &#40;mL&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Positivo&#60;<span class="elsevierStyleHsp" style=""></span>60&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;87<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#44;8&#40;8&#44;2-59&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;52<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#44;70&#40;7&#44;4-59&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">27&#44;81<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#44;31&#40;6&#44;3-63&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;053&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#62;<span class="elsevierStyleHsp" style=""></span>30 mL&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">36&#44;11<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>7&#44;17&#40;24&#44;2-59&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;21<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#44;77&#40;30&#44;2-59&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">36&#44;69<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#44;62&#40;30&#44;3-63&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;652&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;<span class="elsevierStyleHsp" style=""></span>30 mL&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22&#44;32<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>6&#44;57&#40;8&#44;2-29&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;78<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#44;98&#40;7&#44;4-29&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">20&#44;55<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#44;98&#40;6&#44;3-28&#44;6&#44;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;002</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Proteinuria &#40;mg&#47;24h&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0-15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1377&#44;81<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2095&#44;39&#40;63-9540&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1035&#44;43<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1687&#44;85&#40;48-9240&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1167&#44;61<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1560&#44;47&#40;83&#44;6-7463&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;299&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2249489.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de las variables de funci&#243;n renal y proteinuria durante el estudio</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Tabla 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media basal<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 1 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 4 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">p valor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Ca &#40;mg&#47;dL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#44;1-10&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&#44;25<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;66&#40;8-12&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&#44;39<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;54&#40;8&#44;1-10&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&#44;39<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;52&#40;8&#44;5-10&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;112&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">P &#40;mg&#47;dL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#44;7-5&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#44;57<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;80&#40;2&#44;2-5&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#44;72<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;78&#40;1&#44;8-5&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#44;78<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;69&#40;2&#44;2-5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;066&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">PTHi &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">15-65&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">158&#44;17<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>90&#44;23&#40;75-472&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">110&#44;34<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>67&#44;6&#40;75-307&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">119<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>87&#44;79&#40;40-368&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;002</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Calcidiol &#40;ng&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#62;<span class="elsevierStyleHsp" style=""></span>30&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">21&#44;35<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>8&#44;59&#40;8&#44;2-46&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22&#44;22<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#44;17&#40;5-53&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">26&#44;22<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>13&#44;15&#40;10-35&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;010</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">iFGF23 &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&#44;9-2400&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">112&#44;80<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>81&#44;12&#40;17&#44;1-<span class="elsevierStyleItalic">359</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">110&#44;96<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>98&#44;86&#40;17-583&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">106&#44;60<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>95&#44;51&#40;25-<span class="elsevierStyleItalic">437</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;577&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Klotho &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7&#44;8-500&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">218&#44;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>113&#44;62&#40;45&#44;7-407&#44;6<span class="elsevierStyleItalic">&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">245&#44;53<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>126&#44;48&#40;60&#44;3-518&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">284&#44;60<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>138&#44;17&#40;54&#44;6-565&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2249490.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de las variables bioqu&#237;micas de EOM-ERC durante el estudio</p>"
        ]
      ]
      5 => array:8 [
        "identificador" => "tbl0020"
        "etiqueta" => "Tabla 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at4"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media basal<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 1 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 4 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">p valor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">PCR &#40;mg&#47;dL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;00-0&#44;80&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#44;13 &#40;&#177;3&#44;24&#41;&#40;0&#44;0-21&#44;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;85 &#40;&#177;1&#44;71&#41;&#40;0&#44;0-7&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;70 &#40;&#177;1&#44;45&#41;&#40;0&#44;0-9&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;182&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">IL6 &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;156-10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">32&#44;9 &#40;&#177;16&#44;40&#41;&#40;10&#44;1-92&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">30 &#40;&#177;15&#44;49&#41;&#40;10&#44;1-75&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23&#44;10 &#40;&#177;9&#44;94&#41;&#40;6&#44;2-48&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">IL10 &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;78-50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12&#44;80 &#40;&#177;6&#44;10&#41;&#40;4&#44;6-35&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">18&#44;39 &#40;&#177;8&#44;09&#41;&#40;3&#44;6-53&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19&#44;60 &#40;&#177;7&#44;91&#41;&#40;8&#44;9-37&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TNF-&#945; &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;5-32&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">13&#44;70 &#40;&#177;12&#44;02&#41;&#40;0&#44;9-70&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12&#44;11 &#40;&#177;10&#44;90&#41;&#40;1&#44;6-56&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#44;80 &#40;&#177;6&#44;28&#41;&#40;2&#44;2-34&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;005</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fetu&#237;na A g&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;698-2&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;20<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;08&#40;0&#44;1-0&#44;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;23<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;10&#40;0&#44;1-0&#44;39&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;27<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;16&#40;0&#44;1-0&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">&#60;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">0&#44;0001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TGF-&#946;1 pg&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31&#44;20-2000&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6584&#44;91<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3468&#44;662013&#44;8-15892&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6224&#44;42<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3462&#44;861782&#44;2-14805&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5631&#44;01<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3167&#44;171892&#44;2-14587&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">&#60;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">0&#44;0001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">BMP-7 pg&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31&#44;20-2000&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#44;55<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;222&#44;58-7&#44;12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#44;95<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;412&#44;56-7&#44;76&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#44;39<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;522&#44;67-8&#44;12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">&#60;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">0&#44;0001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2249487.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los par&#225;metros inflamatorios&#44; fibrosis y calcificaci&#243;n vascular</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:52 [
            0 => array:3 [
              "identificador" => "bib0265"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recomendaciones de la Sociedad Espa&#241;ola de Nefrolog&#237;a para el manejo de las alteraciones del metabolismo &#243;seo-mineral en los pacientes con enfermedad renal cr&#243;nica"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;V&#46; Torregrosa"
                            1 => "J&#46; Bover Sanju&#225;n"
                            2 => "J&#46; Cannata And&#237;a"
                            3 => "F&#46; Caravaca"
                            4 => "V&#46; Lorenzo"
                            5 => "A&#46;L&#46; Mart&#237;n de Francisco"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3265/Nefrologia.pre2011.Jan.10816"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nefrologia&#46;"
                        "fecha" => "2011"
                        "volumen" => "31"
                        "paginaInicial" => "3"
                        "paginaFinal" => "32"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21468161"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "KDIGO 2017 Clinical practice guideline update for the diagnosis&#44; evaluation&#44; prevention&#44; and treatment of chronic kidney disease&#8211;mineral and bone disorder &#40;CKD-MBD&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Isakova"
                            1 => "T&#46;L&#46; Nickolas"
                            2 => "M&#46; Denburg"
                            3 => "S&#46; Yarlagadda"
                            4 => "D&#46;E&#46; Weiner"
                            5 => "O&#46;M&#46; Guti&#233;rrez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Kidney Int Supplements&#46;"
                        "fecha" => "2017"
                        "paginaInicial" => "1"
                        "paginaFinal" => "59"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mechanistic insights into vascular calcification in CKD"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Shroff"
                            1 => "D&#46;A&#46; Long"
                            2 => "C&#46; Shanahan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2011121191"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2013"
                        "volumen" => "24"
                        "paginaInicial" => "179"
                        "paginaFinal" => "189"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23138485"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Update on chronic&#160;kidney disease&#160;mineral and bone disorder in cardiovascular&#160;disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46; Lunyera"
                            1 => "J&#46;J&#46; Scialla"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Semin Nephrol&#46;"
                        "fecha" => "2018"
                        "volumen" => "38"
                        "paginaInicial" => "542"
                        "paginaFinal" => "558"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Klotho deficiency causes vascular calcification in chronic kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;C&#46; Hu"
                            1 => "M&#46; Shi"
                            2 => "J&#46; Zhang"
                            3 => "H&#46; Quinones"
                            4 => "C&#46; Griffith"
                            5 => "M&#46; Kuro-o"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "124"
                        "paginaFinal" => "136"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Plasma Fetuin A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver diseas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Roos"
                            1 => "J&#46; Lutz"
                            2 => "H&#46; Salmhofer"
                            3 => "F&#46; Aslan"
                            4 => "C&#46;N&#46; Ercin"
                            5 => "F&#46; Ors"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2265.2012.04460.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clinical Endocrinology&#46;"
                        "fecha" => "2013"
                        "volumen" => "78"
                        "paginaInicial" => "712"
                        "paginaFinal" => "717"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22676641"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0295"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bone morphogenetic proteins in vascular calcification"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "K&#46; Hruska"
                            1 => "S&#46; Mathew"
                            2 => "G&#46; Saab"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/01.RES.00000175571.53833.6c"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circ Res&#46;"
                        "fecha" => "2005"
                        "volumen" => "97"
                        "paginaInicial" => "105"
                        "paginaFinal" => "114"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16037577"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0300"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The expanding spectrum of biological actions of vitamin D"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46; Rojas-Rivera"
                            1 => "C&#46; de La Piedra"
                            2 => "A&#46; Ramos"
                            3 => "A&#46; Ortiz"
                            4 => "J&#46; Egido"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfq313"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol&#46; Dial&#46; Transplant&#46;"
                        "fecha" => "2010"
                        "volumen" => "25"
                        "paginaInicial" => "2850"
                        "paginaFinal" => "2865"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20525641"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0305"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "receptor agonist increase Klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:7 [
                            0 => "W&#46;L&#46; Lau"
                            1 => "E&#46;M&#46; Leaf"
                            2 => "M&#46;C&#46; Hu"
                            3 => "M&#46;M&#46; Takeno"
                            4 => "M&#46; Kuro-o"
                            5 => "O&#46;W&#46; Moe"
                            6 => "D&#46; Vitamin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.2012.322"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2012"
                        "volumen" => "82"
                        "paginaInicial" => "1261"
                        "paginaFinal" => "1270"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22932118"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0310"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vitamin D attenuates endothelial dysfunction in uremic rats and maintains human endothelial stability"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Vila Cuenca"
                            1 => "E&#46; Ferrantelli"
                            2 => "E&#46; Meinster"
                            3 => "S&#46;M&#46; Pouw"
                            4 => "I&#46; Kova&#269;evi&#263;"
                            5 => "R&#46;X&#46; de Menezes"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/JAHA.118.760087"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Heart Assoc&#46;"
                        "fecha" => "2018"
                        "volumen" => "7"
                        "paginaInicial" => "e008776"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30371149"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0315"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Double treatment with paricalcitol-associated calcifediol and cardiovascular risk biomarkers in haemodialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Pi&#241;era"
                            1 => "M&#46;A&#46; Izquierdo"
                            2 => "L&#46;A&#46; Mart&#237;n de Francisco"
                            3 => "M&#46;T&#46; Garc&#237;a-Unzueta"
                            4 => "M&#46; L&#243;pez-Hoyos"
                            5 => "C&#46; Toyos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Nefrolog&#237;a&#46;"
                        "fecha" => "2013"
                        "volumen" => "18"
                        "paginaInicial" => "77"
                        "paginaFinal" => "84"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0320"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;J&#46; Izquierdo"
                            1 => "M&#46; Cavia"
                            2 => "P&#46; Mu&#241;iz"
                            3 => "A&#46;L&#46; de Francisco"
                            4 => "M&#46; Arias"
                            5 => "J&#46; Santos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "BMC Nephrology&#46;"
                        "fecha" => "2012"
                        "volumen" => "27"
                        "paginaInicial" => "159"
                        "paginaFinal" => "165"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0325"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Differential&#160;effects&#160;of&#160;vitamin D&#160;analogs&#160;on&#160;vascular calcification"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Card&#250;s"
                            1 => "S&#46; Panizo"
                            2 => "E&#46; Parisi"
                            3 => "E&#46; Fern&#225;ndez"
                            4 => "J&#46;M&#46; Valdivielso"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1359/jbmr.070305"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Bone Miner Res&#46;"
                        "fecha" => "2007"
                        "volumen" => "22"
                        "paginaInicial" => "860"
                        "paginaFinal" => "866"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17352647"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0330"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "High phosphate induces a pro-inflammatory response by vascular smooth muscle cells and modulation by vitamin D derivatives"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;M&#46; Mart&#237;nez-Moreno"
                            1 => "C&#46; Herencia"
                            2 => "A&#46;M&#46; de Oca"
                            3 => "J&#46;M&#46; D&#237;az-Tocados"
                            4 => "N&#46; Vergara"
                            5 => "M&#46;J&#46; G&#243;mez-Luna"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1042/CS20160807"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Sci&#46;"
                        "fecha" => "2017"
                        "volumen" => "131"
                        "paginaInicial" => "1449"
                        "paginaFinal" => "1463"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28442557"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0335"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Management of cardiovascular disease in patients with kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M&#46;R&#46; Kahn"
                            1 => "M&#46;J&#46; Robbins"
                            2 => "M&#46;C&#46; Kim"
                            3 => "V&#46; Fuster"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrcardio.2013.15"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat&#46; Rev&#46; Cardiol&#46;"
                        "fecha" => "2013"
                        "volumen" => "10"
                        "paginaInicial" => "261"
                        "paginaFinal" => "273"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23419899"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0340"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Associations of plasma 25 Hydroxyvitamin D and 1&#44;25-Dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Kendrick"
                            1 => "A&#46;K&#46; Cheung"
                            2 => "J&#46; Kaufman"
                            3 => "T&#46; Greene"
                            4 => "W&#46;L&#46; Roberts"
                            5 => "G&#46; Smits"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.ajkd.2012.04.014"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Kidney Dis&#46;"
                        "fecha" => "2012"
                        "volumen" => "60"
                        "paginaInicial" => "567"
                        "paginaFinal" => "575"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22621970"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0345"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Inflammation and oxidative stress in ESRD &#8211; the role of myeloperoxidase"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Y&#46; Maruyama"
                            1 => "B&#46; Lindholm"
                            2 => "P&#46; Stenvinkel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Nephrol&#46;"
                        "fecha" => "2004"
                        "volumen" => "17"
                        "paginaInicial" => "72"
                        "paginaFinal" => "76"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0350"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patient"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Capuano"
                            1 => "V&#46; Serio"
                            2 => "A&#46; Pota"
                            3 => "B&#46; Memoli"
                            4 => "V&#46;E&#46; Andreucci"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Nephrol&#46;"
                        "fecha" => "2009"
                        "volumen" => "22"
                        "paginaInicial" => "59"
                        "paginaFinal" => "68"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19229819"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0355"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Selective Vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes &#40;VITAL study&#41;&#58; a randomised controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Zeeuw"
                            1 => "R&#46; Agarwal"
                            2 => "M&#46; Amdahl"
                            3 => "P&#46; Audhya"
                            4 => "D Coyne"
                            5 => "T&#46; Garimella"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)61032-X"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet&#46;"
                        "fecha" => "2010"
                        "volumen" => "376"
                        "paginaInicial" => "1543"
                        "paginaFinal" => "1551"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21055801"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0360"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antiproteinuric effect of oral paricalcitol in chronic kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Agarwal"
                            1 => "M&#46; Acharya"
                            2 => "J&#46; Tian"
                            3 => "R&#46;L&#46; Hippensteel"
                            4 => "J&#46;Z&#46; Melnick"
                            5 => "P&#46; Qiu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1523-1755.2005.00755.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2005"
                        "volumen" => "68"
                        "paginaInicial" => "2823"
                        "paginaFinal" => "2828"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16316359"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0365"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Yanagisawa"
                            1 => "Y&#46; Yanagi"
                            2 => "Y&#46; Masuhiro"
                            3 => "M&#46; Suzawa"
                            4 => "M&#46; Watanabe"
                            5 => "K&#46; Kashiwagi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Science"
                        "fecha" => "1999"
                        "volumen" => "283"
                        "paginaInicial" => "1317"
                        "paginaFinal" => "1321"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0370"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Selective Vitamin D receptor activation as anti-inflammatory target in chronic kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Donate"
                            1 => "V&#46; Dom&#237;nguez"
                            2 => "M&#46;L&#46; M&#233;ndez"
                            3 => "M&#46; Muros-de-Fuentes"
                            4 => "C&#46; Mora-Fern&#225;ndez"
                            5 => "E&#46; Mart&#237;n-N&#250;&#241;ez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1155/2014/670475"
                      "Revista" => array:3 [
                        "tituloSerie" => "Mediators of Inflammation&#46;"
                        "fecha" => "2014"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18475648"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0375"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "1&#44;25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Y&#46;C&#46; Li"
                            1 => "J&#46; Kong"
                            2 => "M&#46; Wei"
                            3 => "Z&#46;F&#46; Chen"
                            4 => "S&#46;Q&#46; Liu"
                            5 => "L&#46;P&#46; Cao"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1172/JCI15219"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Invest&#46;"
                        "fecha" => "2002"
                        "volumen" => "110"
                        "paginaInicial" => "229"
                        "paginaFinal" => "238"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12122115"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0380"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Mizobuchi"
                            1 => "J&#46; Morrissey"
                            2 => "J&#46;L&#46; Finch"
                            3 => "D&#46;R&#46; Martin"
                            4 => "H&#46; Liapis"
                            5 => "T&#46; Akizawa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2006091028"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2007"
                        "volumen" => "18"
                        "paginaInicial" => "1796"
                        "paginaFinal" => "1806"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17513326"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0385"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "X&#46;X&#46; Wang"
                            1 => "T&#46; Jiang"
                            2 => "Y&#46; Shen"
                            3 => "H&#46; Santamaria"
                            4 => "H&#46; Santamaria"
                            5 => "N&#46; Solis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1152/ajprenal.00338.2010"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Physiol Renal Physiol&#46;"
                        "fecha" => "2011"
                        "volumen" => "300"
                        "paginaInicial" => "F801"
                        "paginaFinal" => "F810"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21209008"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0390"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Receptor agonists in the treatment of autoimmune diseases&#58; selective targeting of myeloid but not plasmacytoid dendritic cells"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "G&#46; Penna"
                            1 => "S&#46; Amuchastegui"
                            2 => "G&#46; Laverny"
                            3 => "L&#46; Adorini"
                            4 => "D&#46; Vitamin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Journal Of Bone And Mineral Research&#46;"
                        "fecha" => "2007"
                        "volumen" => "22"
                        "paginaInicial" => "69"
                        "paginaFinal" => "73"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0395"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "1&#44;25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Penna"
                            1 => "S&#46; Amuchastegui"
                            2 => "N&#46; Giarratana"
                            3 => "K&#46;C&#46; Daniel"
                            4 => "M&#46; Vulcano"
                            5 => "S&#46; Sozzani"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Immunol&#46;"
                        "fecha" => "2007"
                        "volumen" => "178"
                        "paginaInicial" => "145"
                        "paginaFinal" => "153"
                        "itemHostRev" => array:3 [
                          "pii" => "S1473309916301207"
                          "estado" => "S300"
                          "issn" => "14733099"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0400"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 Production"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Gonz&#225;lez-Mateo"
                            1 => "V&#46; Fern&#225;ndez-M&#237;llara"
                            2 => "T&#46; Bell&#243;n"
                            3 => "G&#46; Liappas"
                            4 => "M&#46; Ruiz-Ortega"
                            5 => "M&#46; L&#243;pez-Cabrera"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0108477"
                      "Revista" => array:5 [
                        "tituloSerie" => "Plos One&#46;"
                        "fecha" => "2014"
                        "volumen" => "9"
                        "paginaInicial" => "e108477"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25279459"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0405"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Switch from calcitriol to paricalcitol in secondary hyperparathyroidism of hemodialysis patients&#58; Responsiveness is related to parathyroid gland size"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Vulpio"
                            1 => "G&#46; Maresca"
                            2 => "E&#46; Distasio"
                            3 => "S&#46; Cacaci"
                            4 => "N&#46; Panocchia"
                            5 => "G&#46; Luciani"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1542-4758.2010.00514.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hemodial Int&#46;"
                        "fecha" => "2011"
                        "volumen" => "15"
                        "paginaInicial" => "69"
                        "paginaFinal" => "78"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21223484"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0410"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Low-dose cholecalciferol supplementation and dual vitamin D&#160;therapy&#160;in haemodialysis&#160;patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "N&#46; Mittman"
                            1 => "R&#46; Khana"
                            2 => "S&#46; Rani"
                            3 => "J&#46; Hor&#225;&#269;ek"
                            4 => "L&#46; Pavl&#237;kov&#225;"
                            5 => "V&#46; Pali&#269;ka"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Int Urol Nephrol&#46;"
                        "fecha" => "2015"
                        "volumen" => "47"
                        "paginaInicial" => "169"
                        "paginaFinal" => "176"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0415"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patient"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Capuano"
                            1 => "V&#46; Serio"
                            2 => "A&#46; Pota"
                            3 => "B&#46; Memoli"
                            4 => "V&#46;E&#46; Andreucci"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Nephrol&#46;"
                        "fecha" => "2009"
                        "volumen" => "22"
                        "paginaInicial" => "59"
                        "paginaFinal" => "68"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19229819"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0420"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Klotho&#46; An elixir of youth for the vasculature&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46; Shroff"
                            1 => "C&#46; Shanahan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Soc Nephrol"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "5"
                        "paginaFinal" => "7"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0425"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Soluble Klotho protects against uremic cardiomyopathy independently of Fibroblast Growth Factor 23 and phosphate"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46; Xie"
                            1 => "J&#46; Yoon"
                            2 => "S&#46;W&#46; An"
                            3 => "M&#46; Kuro"
                            4 => "M&#46; Kuro-o"
                            5 => "C&#46;L&#46; Huang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J AmSoc Nephrol&#46;"
                        "fecha" => "2015"
                        "volumen" => "26"
                        "paginaInicial" => "1150"
                        "paginaFinal" => "1160"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0430"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46; Xie"
                            1 => "S&#46;-K&#46; Cha"
                            2 => "S&#46;-W&#46; An"
                            3 => "M&#46; Kuro-O"
                            4 => "L&#46; Birnbaumer"
                            5 => "C&#46;L&#46; Huang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ncomms2240"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Commun&#46;"
                        "fecha" => "2012"
                        "volumen" => "3"
                        "paginaInicial" => "1238"
                        "paginaFinal" => "1259"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23212367"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0435"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Klotho depletion contributes to increased inflam-mation in kidney of the db&#47;db mouse model of diabetes via RelA &#40;serine&#41;536 phosphorylation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Zhao"
                            1 => "S&#46; Banerjee"
                            2 => "N&#46; Dey"
                            3 => "W&#46;S&#46; LeJeune"
                            4 => "P&#46;S&#46; Sarkar"
                            5 => "R&#46; Brobey"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Diabetes&#46;"
                        "fecha" => "2011"
                        "volumen" => "60"
                        "paginaInicial" => "1907"
                        "paginaFinal" => "1916"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0440"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The inflammatory cytokines TWEAK and TNF a reduce renal Klotho expression through NF-kB"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;A&#46; Moreno"
                            1 => "M&#46;C&#46; Izquierdo"
                            2 => "M&#46;D&#46; Sanchez-Ni&#241;o"
                            3 => "B&#46; Su&#225;rez-&#193;lvarez"
                            4 => "C&#46; L&#243;pez Larrea"
                            5 => "A&#46; Jakubowski"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2010101073"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "1315"
                        "paginaFinal" => "1325"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21719790"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0445"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The emerging role of Klotho in clinical nephrology"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "M&#46;C&#46; Hu"
                            1 => "M&#46; Kuro"
                            2 => "O&#46; Moe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfs160"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol Dial Transplant&#46;"
                        "fecha" => "2012"
                        "volumen" => "27"
                        "paginaInicial" => "2650"
                        "paginaFinal" => "2657"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22802580"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0450"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis&#58; results of the IMPACT SHPT study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Ketteler"
                            1 => "K&#46;J&#46; Martin"
                            2 => "M&#46; Wolf"
                            3 => "M&#46; Amdahl"
                            4 => "M&#46; Cozzolino"
                            5 => "D&#46; Goldsmith"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Nephrol Dial Transplant&#46;"
                        "fecha" => "2012"
                        "volumen" => "27"
                        "paginaInicial" => "3270"
                        "paginaFinal" => "3278"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib0455"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of cinacalcet and Vitamin D analogs on Fibroblast Growth Factor-23 during the treatment of secondary hyperparathyroidism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46;M&#46; Sprague"
                            1 => "J&#46;B&#46; Wetmore"
                            2 => "K&#46; Gurevich"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2215/CJN.03270314"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin J Am Soc Nephrol&#46;"
                        "fecha" => "2015"
                        "volumen" => "10"
                        "paginaInicial" => "1021"
                        "paginaFinal" => "1030"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25873267"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib0460"
              "etiqueta" => "40"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fibroblast Growth Factor 23 is not associated with and does not induce arterial calcification"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;J&#46; Scialla"
                            1 => "W&#46;L&#46; Lau"
                            2 => "M&#46;P&#46; Reilly"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.2013.3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2013"
                        "volumen" => "83"
                        "paginaInicial" => "1159"
                        "paginaFinal" => "1168"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23389416"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bib0465"
              "etiqueta" => "41"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Serum FGF 23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46; &#196;rnl&#246;v"
                            1 => "A&#46;C&#46; Carlsson"
                            2 => "J&#46; Sundstr&#246;m"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2215/CJN.09570912"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin J Am Soc Nephrol&#46;"
                        "fecha" => "2013"
                        "volumen" => "8"
                        "paginaInicial" => "781"
                        "paginaFinal" => "786"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23335040"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bib0470"
              "etiqueta" => "42"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fibroblast Growth Factor 23 is associated with proteinuria and smoking in chronic kidney disease&#58; an analysis of the MASTERPLAN cohort"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;G&#46; Vervloet"
                            1 => "A&#46;D&#46; van Zuilen"
                            2 => "P&#46;J&#46; Blankestijn"
                            3 => "P&#46;M&#46; ter Wee"
                            4 => "M&#46;L&#46; Bots"
                            5 => "P&#46;J&#46; Blankestijn"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Bio Med Central Nephrology&#46;"
                        "fecha" => "2012"
                        "volumen" => "24"
                        "paginaInicial" => "13"
                        "paginaFinal" => "20"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bib0475"
              "etiqueta" => "43"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "FGF 23 associates with death&#44; cardiovascular events&#44; and initiation of chronic dialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Kendrick"
                            1 => "A&#46;K&#46; Cheung"
                            2 => "J&#46;S&#46; Kaufman"
                            3 => "T&#46; Greene"
                            4 => "W&#46;L&#46; Roberts"
                            5 => "G&#46; Smits"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2010121224"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "1913"
                        "paginaFinal" => "1922"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21903574"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bib0480"
              "etiqueta" => "44"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hyperhomocysteinemia in end-stage renal disease&#58; prevalence&#44; etiology&#44; and potential relationship to arteriosclerotic outcomes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46;G&#46; Bostom"
                            1 => "L&#46; Lathrop"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.1997.298"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "1997"
                        "volumen" => "52"
                        "paginaInicial" => "10"
                        "paginaFinal" => "20"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9211341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bib0485"
              "etiqueta" => "45"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-inflammatory effects of short chain fatty acids in IFN-gammastimulated RAW 264&#46;7 murine macrophage cells&#58; involvement of NF-kappaB and ERK signaling pathways"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46;S&#46; Park"
                            1 => "E&#46;J&#46; Lee"
                            2 => "J&#46;C&#46; Lee"
                            3 => "W&#46;K&#46; Kim"
                            4 => "H&#46;S&#46; Kim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Int Immunopharmacol&#46;"
                        "fecha" => "2007"
                        "volumen" => "7"
                        "paginaInicial" => "70"
                        "paginaFinal" => "77"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bib0490"
              "etiqueta" => "46"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Association of high alpha2-Heremans-Schmid glycoprotein&#47;Fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;E&#46; Fiore"
                            1 => "G&#46; Celotta"
                            2 => "G&#46; Politi"
                            3 => "L&#46; di Pino"
                            4 => "Z&#46; Castelli"
                            5 => "R&#46;A&#46; Mangiafico"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.atherosclerosis.2006.08.052"
                      "Revista" => array:6 [
                        "tituloSerie" => "Atherosclerosis&#46;"
                        "fecha" => "2007"
                        "volumen" => "195"
                        "paginaInicial" => "110"
                        "paginaFinal" => "115"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17010978"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bib0495"
              "etiqueta" => "47"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46;J&#46; Lund"
                            1 => "M&#46; Davies"
                            2 => "A&#46; Brown"
                            3 => "K&#46;A&#46; Hruska"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/01.asn.0000109671.99498.08"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol"
                        "fecha" => "2004"
                        "volumen" => "15"
                        "paginaInicial" => "359"
                        "paginaFinal" => "369"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14747382"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bib0500"
              "etiqueta" => "48"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bone morphogenetic protein 7&#58; a novel treatment for chronic renal and bone disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "Li Tingting"
                            1 => "K&#46; Surendran"
                            2 => "M&#46; Zawaideh"
                            3 => "S&#46; Mathew"
                            4 => "K&#46;A&#46; Hruska"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0896860819893805"
                      "Revista" => array:6 [
                        "tituloSerie" => "Current Opinion in Nephrology &#38; Hypertension"
                        "fecha" => "2004"
                        "volumen" => "13"
                        "paginaInicial" => "417"
                        "paginaFinal" => "422"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32063210"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            48 => array:3 [
              "identificador" => "bib0505"
              "etiqueta" => "49"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bone morphogenetic protein-7 &#40;osteogenic protein-1&#41; inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "H&#46; Dorai"
                            1 => "S&#46; Vukicevic"
                            2 => "T&#46;K&#46; Sampath"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Cellular Physiol&#46;"
                        "fecha" => "2000"
                        "volumen" => "184"
                        "paginaInicial" => "37"
                        "paginaFinal" => "45"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            49 => array:3 [
              "identificador" => "bib0510"
              "etiqueta" => "50"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fibroblast growth factor signaling in the vasculature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "X&#46; Yang"
                            1 => "L&#46; Liaw"
                            2 => "I&#46; Prudovsky"
                            3 => "P&#46;C&#46; Brooks"
                            4 => "C&#46; Vary"
                            5 => "L&#46; Oxburgh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s11883-015-0509-6"
                      "Revista" => array:5 [
                        "tituloSerie" => "Curr Atheroscler Rep&#46;"
                        "fecha" => "2015"
                        "volumen" => "17"
                        "paginaInicial" => "509"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25813213"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            50 => array:3 [
              "identificador" => "bib0515"
              "etiqueta" => "51"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mesenchymal stem cells recruited by active TGFb contribute to osteogenic vascular calcification"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46; Wang"
                            1 => "C&#46; Li"
                            2 => "L&#46; Pang"
                            3 => "C&#46; Shi"
                            4 => "F&#46; Guo"
                            5 => "A&#46; Chen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1089/scd.2013.0528"
                      "Revista" => array:6 [
                        "tituloSerie" => "Stem Cells and Development&#46;"
                        "fecha" => "2014"
                        "volumen" => "23"
                        "paginaInicial" => "1392"
                        "paginaFinal" => "1404"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24512598"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            51 => array:3 [
              "identificador" => "bib0520"
              "etiqueta" => "52"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New insights into epithelial-mesenchymal transition in kidney fibrosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Y&#46; Liu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2008121226"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2010"
                        "volumen" => "21"
                        "paginaInicial" => "212"
                        "paginaFinal" => "222"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20019167"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02116995/0000004000000002/v1_202002280639/S0211699519301602/v1_202002280639/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "42448"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000004000000002/v1_202002280639/S0211699519301602/v1_202002280639/es/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699519301602?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Original
Efecto regulador de paricalcitol sobre parámetros inflamatorios, fibróticos y anticalcificantes en el paciente con enfermedad renal crónica. Más allá de la regulación de la enfermedad óseo-mineral
Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patiente. Far beyond mineral bone disease regulation
Laura Salanova Villanueva
Autor para correspondencia
aelita.sv@gmail.com

Autor para correspondencia.
, Yohana Gil Giraldo, Begoña Santos Sánchez-Rey, Abelardo Aguilera Peralta
Nefrología, Hospital Universitario de la Princesa, Madrid, España
Leído
6474
Veces
se ha leído el artículo
2477
Total PDF
3997
Total HTML
Compartir estadísticas
 array:25 [
  "pii" => "S0211699519301602"
  "issn" => "02116995"
  "doi" => "10.1016/j.nefro.2019.08.001"
  "estado" => "S300"
  "fechaPublicacion" => "2020-03-01"
  "aid" => "658"
  "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
  "copyrightAnyo" => "2019"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2020;40:171-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 253
    "formatos" => array:3 [
      "EPUB" => 47
      "HTML" => 138
      "PDF" => 68
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:20 [
      "pii" => "S2013251420300432"
      "issn" => "20132514"
      "doi" => "10.1016/j.nefroe.2020.03.012"
      "estado" => "S300"
      "fechaPublicacion" => "2020-03-01"
      "aid" => "658"
      "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
      "documento" => "article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia &#40;English Version&#41;. 2020;40:171-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
        "titulo" => "Paricalcitol regulatory effect on inflammatory&#44; fibrotic and anticalcificating parameters in renal patient&#46; Far beyond mineral bone disease regulation"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "es"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "171"
            "paginaFinal" => "179"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Efecto regulador de paricalcitol sobre par&#225;metros inflamatorios&#44; fibr&#243;ticos y anticalcificantes en el paciente con enfermedad renal cr&#243;nica&#46; M&#225;s all&#225; de la regulaci&#243;n de la enfermedad &#243;seo-mineral"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Fig&#46; 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 2866
                "Ancho" => 1485
                "Tamanyo" => 148966
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">&#40;A and B&#41; Changes in parameters of CKD-MBD &#40;Klotho and FGF-23&#41; throughout the study&#46; &#40;C&#8211;H&#41; Changes in parameters related to inflammation&#44; fibrosis and vascular calcification throughout the study&#46; Values expressed as arithmetic means&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Laura Salanova Villanueva, Yohana Gil Giraldo, Bego&#241;a Santos S&#225;nchez-Rey, Abelardo Aguilera Peralta"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "Laura"
                "apellidos" => "Salanova Villanueva"
              ]
              1 => array:2 [
                "nombre" => "Yohana"
                "apellidos" => "Gil Giraldo"
              ]
              2 => array:2 [
                "nombre" => "Bego&#241;a"
                "apellidos" => "Santos S&#225;nchez-Rey"
              ]
              3 => array:2 [
                "nombre" => "Abelardo"
                "apellidos" => "Aguilera Peralta"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0211699519301602"
          "doi" => "10.1016/j.nefro.2019.08.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699519301602?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420300432?idApp=UINPBA000064"
      "url" => "/20132514/0000004000000002/v1_202005210712/S2013251420300432/v1_202005210712/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S0211699519301730"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2019.07.005"
    "estado" => "S300"
    "fechaPublicacion" => "2020-03-01"
    "aid" => "659"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2020;40:180-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 822
      "formatos" => array:3 [
        "EPUB" => 64
        "HTML" => 433
        "PDF" => 325
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "&#191;Cu&#225;ndo realizar biopsia renal en pacientes con diabetes mellitus tipo<span class="elsevierStyleHsp" style=""></span>2&#63; Modelo predictivo de enfermedad renal no diab&#233;tica"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "180"
          "paginaFinal" => "189"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "When to perform renal biopsy in patients with type<span class="elsevierStyleHsp" style=""></span>2 diabetes mellitus&#63; Predictive model of non-diabetic renal disease"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figura 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1082
              "Ancho" => 2220
              "Tamanyo" => 143019
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">N&#250;mero de pacientes con nefropat&#237;a diab&#233;tica &#40;ND&#41; y enfermedad renal no diab&#233;tica &#40;ERND&#41; seg&#250;n puntuaci&#243;n del <span class="elsevierStyleItalic">score</span>&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Florencio Garc&#237;a-Mart&#237;n, Esther Gonz&#225;lez Monte, Eduardo Hern&#225;ndez Mart&#237;nez, Teresa Bada Boch, Norman E&#46; Bustamante Jim&#233;nez, Manuel Praga Terente"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Florencio"
              "apellidos" => "Garc&#237;a-Mart&#237;n"
            ]
            1 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "Gonz&#225;lez Monte"
            ]
            2 => array:2 [
              "nombre" => "Eduardo"
              "apellidos" => "Hern&#225;ndez Mart&#237;nez"
            ]
            3 => array:2 [
              "nombre" => "Teresa"
              "apellidos" => "Bada Boch"
            ]
            4 => array:2 [
              "nombre" => "Norman E&#46;"
              "apellidos" => "Bustamante Jim&#233;nez"
            ]
            5 => array:2 [
              "nombre" => "Manuel"
              "apellidos" => "Praga Terente"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2013251420300444"
        "doi" => "10.1016/j.nefroe.2020.03.013"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420300444?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699519301730?idApp=UINPBA000064"
    "url" => "/02116995/0000004000000002/v1_202002280639/S0211699519301730/v1_202002280639/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0211699519301547"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2019.06.008"
    "estado" => "S300"
    "fechaPublicacion" => "2020-03-01"
    "aid" => "652"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2020;40:160-70"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 263
      "formatos" => array:3 [
        "EPUB" => 45
        "HTML" => 140
        "PDF" => 78
      ]
    ]
    "es" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Inflexibilidad psicol&#243;gica e impacto cl&#237;nico&#58; adaptaci&#243;n del Cuestionario de Aceptaci&#243;n y Acci&#243;n-II en una muestra de pacientes en tratamiento de hemodi&#225;lisis"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "160"
          "paginaFinal" => "170"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Psychological inflexibility and clinical impact&#58; Adaptation of the acceptance and action questionnaire-II in a sample of patients on haemodialysis treatment"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Carlos J&#46; Delgado Dom&#237;nguez, Javier Varas Garc&#237;a, Francisco J&#46; Ruiz, Beatriz D&#237;az Espejo, Petra Cant&#243;n Guerrero, Elena Ruiz S&#225;nchez, Noelia Gonz&#225;lez Jurado, Abraham Rinc&#243;n Bello, Rosa Ramos S&#225;nchez"
          "autores" => array:9 [
            0 => array:2 [
              "nombre" => "Carlos J&#46;"
              "apellidos" => "Delgado Dom&#237;nguez"
            ]
            1 => array:2 [
              "nombre" => "Javier"
              "apellidos" => "Varas Garc&#237;a"
            ]
            2 => array:2 [
              "nombre" => "Francisco J&#46;"
              "apellidos" => "Ruiz"
            ]
            3 => array:2 [
              "nombre" => "Beatriz"
              "apellidos" => "D&#237;az Espejo"
            ]
            4 => array:2 [
              "nombre" => "Petra"
              "apellidos" => "Cant&#243;n Guerrero"
            ]
            5 => array:2 [
              "nombre" => "Elena"
              "apellidos" => "Ruiz S&#225;nchez"
            ]
            6 => array:2 [
              "nombre" => "Noelia"
              "apellidos" => "Gonz&#225;lez Jurado"
            ]
            7 => array:2 [
              "nombre" => "Abraham"
              "apellidos" => "Rinc&#243;n Bello"
            ]
            8 => array:2 [
              "nombre" => "Rosa"
              "apellidos" => "Ramos S&#225;nchez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2013251420300390"
        "doi" => "10.1016/j.nefroe.2019.06.006"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420300390?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699519301547?idApp=UINPBA000064"
    "url" => "/02116995/0000004000000002/v1_202002280639/S0211699519301547/v1_202002280639/es/main.assets"
  ]
  "es" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
    "titulo" => "Efecto regulador de paricalcitol sobre par&#225;metros inflamatorios&#44; fibr&#243;ticos y anticalcificantes en el paciente con enfermedad renal cr&#243;nica&#46; M&#225;s all&#225; de la regulaci&#243;n de la enfermedad &#243;seo-mineral"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "171"
        "paginaFinal" => "179"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Laura Salanova Villanueva, Yohana Gil Giraldo, Bego&#241;a Santos S&#225;nchez-Rey, Abelardo Aguilera Peralta"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "Laura"
            "apellidos" => "Salanova Villanueva"
            "email" => array:1 [
              0 => "aelita.sv@gmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Yohana"
            "apellidos" => "Gil Giraldo"
          ]
          2 => array:2 [
            "nombre" => "Bego&#241;a"
            "apellidos" => "Santos S&#225;nchez-Rey"
          ]
          3 => array:2 [
            "nombre" => "Abelardo"
            "apellidos" => "Aguilera Peralta"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Nefrolog&#237;a&#44; Hospital Universitario de la Princesa&#44; Madrid&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Paricalcitol regulatory effect on inflammatory&#44; fibrotic and anticalcificating parameters in renal patiente&#46; Far beyond mineral bone disease regulation"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1426
            "Ancho" => 2091
            "Tamanyo" => 250652
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Esquema de investigaci&#243;n cl&#237;nica&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Introducci&#243;n</span><p id="par0005" class="elsevierStylePara elsevierViewall">La enfermedad &#243;seo-mineral &#40;EOM&#41; relacionada con la enfermedad renal cr&#243;nica &#40;ERC&#41; &#8211;EOM-ERC&#8211; conlleva alteraciones bioqu&#237;micas como aumento de calcio &#40;Ca&#41;&#44; f&#243;sforo &#40;P&#41;&#44; hormona paratiroidea &#40;PTH&#41;&#44; calcitriol&#44; factor de crecimiento fibrobl&#225;stico 23 &#40;FGF-23&#41; y descenso de Klotho<a class="elsevierStyleCrossRefs" href="#bib0265"><span class="elsevierStyleSup">1&#44;2</span></a>&#59; estas alteraciones contribuyen a la calcificaci&#243;n vascular de distintas maneras&#58; la hiperfosfatemia&#44; el descenso de Klotho y de vitamina D activa&#44; y el aumento de FGF-23 promueven la entrada de P por los canales Pit1&#47;2 en las c&#233;lulas vasculares del m&#250;sculo liso con su consiguiente trasformaci&#243;n osteog&#233;nica<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">3&#8211;5</span></a>&#46; Otros factores que influyen en el desarrollo de la calcificaci&#243;n vascular en la ERC ser&#237;an la alteraci&#243;n de par&#225;metros relacionados con la inflamaci&#243;n y la fibrosis&#44; como el descenso de fetu&#237;na A &#40;Ft-A&#41; y de la prote&#237;na morfog&#233;nica &#243;sea 7 &#40;BMP-7&#41; o el aumento del factor de necrosis tumoral &#945; &#40;TNF-&#945;&#41; y del factor de crecimiento transformante &#946; &#40;TGF-&#946;&#41;<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">3-9</span></a>&#46; Este ambiente procalcificante del paciente con ERC justifica su alto riesgo cardiovascular<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">3</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Calcitriol y los an&#225;logos para el receptor de vitamina D &#40;AVDR&#41;&#44; como paricalcitol &#40;PRCT&#41;&#44; adem&#225;s de regular los niveles de PTH&#44; Ca o P&#44; presentan efectos pleiotr&#243;picos a nivel sist&#233;mico<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">8</span></a>&#59; uno de ellos es la protecci&#243;n endotelial<a class="elsevierStyleCrossRefs" href="#bib0305"><span class="elsevierStyleSup">9&#44;10</span></a>&#46; Distintos estudios han demostrado que calcitriol y AVDR protegen al endotelio de la calcificaci&#243;n al inhibir prote&#237;nas calcificantes como <span class="elsevierStyleItalic">matrix</span> gla prote&#237;na y reduciendo citoquinas proinflamatorias<a class="elsevierStyleCrossRefs" href="#bib0315"><span class="elsevierStyleSup">11&#44;12</span></a>&#46; No obstante el efecto de calcitriol podr&#237;a diferir al de PRCT<a class="elsevierStyleCrossRefs" href="#bib0325"><span class="elsevierStyleSup">13&#44;14</span></a>&#59; calcitriol&#44; a nivel vascular&#44; podr&#237;a tener dos consecuencias antag&#243;nicas</p><p id="par0015" class="elsevierStylePara elsevierViewall">dosis-dependiente&#58; a dosis hipercalcemiantes calcitriol presenta un efecto procalcificante sobre la CMLV mediado en parte por las acciones del P y mol&#233;culas procalcificantes a nivel celular&#59; PRCT no parece presentar esa dualidad</p><p id="par0020" class="elsevierStylePara elsevierViewall">dosis-dependiente<a class="elsevierStyleCrossRefs" href="#bib0325"><span class="elsevierStyleSup">13&#44;14</span></a>&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Por esta raz&#243;n estudiamos el efecto de PRCT sobre la EOM-ERC y mol&#233;culas asociadas a calcificaci&#243;n vascular&#44; inflamaci&#243;n y fibrosis en pacientes con ERC &#40;estadios III-V sin di&#225;lisis&#41; en b&#250;squeda de un efecto modulador sobre los mismos&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Material y m&#233;todos</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Pacientes</span><p id="par0030" class="elsevierStylePara elsevierViewall">Se trata de un estudio prospectivo no controlado realizado en el Hospital Universitario de La Princesa &#40;Madrid&#41;&#46; Preseleccionamos a 59 pacientes estadio III-V sin di&#225;lisis&#44; mayores de edad susceptibles de utilizar PRCT por aumento de PTH seg&#250;n estadificaci&#243;n de su ERC<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">1</span></a>&#58; estadio III<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>70 pg&#47;mL&#44; IV<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>110 pg&#47;mL&#44; estadio V<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>150 pg&#47;mL &#40;Gu&#237;as SEN&#41;&#46; Los criterios de exclusi&#243;n fueron&#58; inclusi&#243;n en terapia sustitutiva renal&#44; fallo card&#237;aco y&#47;o hep&#225;tico agudo&#44; enfermedad infecciosa o inmunol&#243;gica activa y alergia a PRCT &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; Finalmente seleccionamos a 46 pacientes con un seguimiento de cuatro meses en tratamiento con PRCT&#58; 1mcg diario si PTH<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>500 pg&#47;mL y 2 mcg diario si PTH<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>500 pg&#47;mL&#46; Ning&#250;n paciente super&#243; los 500 pg&#47;mL de PTH&#46; Las dosis de PRCT se suspender&#237;an si PTH<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>70 pg&#47;mL&#46; Siete pacientes ten&#237;an prescrito calcidiol&#59; no hubo otros tratamientos relacionados con vitamina D o an&#225;logos&#44; por lo que se realiz&#243; periodo de lavado de un mes previo al inicio del estudio&#46; No hubo p&#233;rdidas de pacientes en el seguimiento durante estos cuatro meses&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Determinaciones</span><p id="par0035" class="elsevierStylePara elsevierViewall">Se realizaron determinaciones anal&#237;ticas sangu&#237;neas y urinarias en el momento basal&#44; al mes y a los cuatro meses de iniciado PRCT&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Las muestras sangu&#237;neas de los test espec&#237;ficos se centrifugaron a 1200 revoluciones por minuto durante 10 minutos&#44; se extrajo el suero&#44; se alicuot&#243; y almacen&#243; a -80<span class="elsevierStyleHsp" style=""></span>&#176;C para su posterior an&#225;lisis&#46; Las determinaciones de ELISA fueron efectuadas de acuerdo al protocolo descrito por el fabricante&#46; Las concentraciones de los par&#225;metros se determinaron por la curva est&#225;ndar y respectivas diluciones&#46; Los par&#225;metros bioqu&#237;micos valorados en cada una de las visitas fueron&#58; creatinina &#40;Cr&#41;&#44; MDRD 4 tasa de filtrado glomerular &#40;TFG&#41;&#44; proteinuria mg&#47;24<span class="elsevierStyleHsp" style=""></span>h&#44; Ca&#44; Pi&#44; calcidiol &#40;Roche&#47;Hitachi Cobas&#41;&#44; PTHi &#40;Roche&#47;Hitachi Cobas&#174;&#58; fragmentos 1-84&#41;&#44; fracci&#243;n soluble Klotho &#40;ELISA Cusabio&#174;&#44; 7&#44;8-500 pg&#47;mL&#41;&#44; iFGF-23 &#40;Millipore&#174;&#59; 9&#44;9-2400 pg&#47;mL&#41;&#46; Par&#225;metros relacionados con la inflamaci&#243;n&#58; interleucina &#40;IL&#41; 6 &#40;R &#38; D&#174;&#44; HS600B&#59; 0&#44;156-10 pg&#47;mL&#41;&#44; TNF<span class="elsevierStyleHsp" style=""></span>&#8722;<span class="elsevierStyleHsp" style=""></span>&#945; &#40;ELISA R &#38; D&#44; HSTA00D&#59; 0&#44;52-32 pg&#47;mL&#41;&#44; IL10 &#40;R &#38; D&#44; 0&#44;78-50 pg&#47;mL&#41;&#44; prote&#237;na C reactiva &#40;PCR&#41; &#40;Roche&#47;Hitachi Cobas&#41; &#174;&#46; Par&#225;metros relacionados con calcificaci&#243;n y fibrosis&#58; Ft-A &#40;Bio Vendor&#59; 0&#44;698-2&#46;330<span class="elsevierStyleHsp" style=""></span>g&#47;L&#41;&#44; BMP-7 &#40;R &#38; D&#59; 31&#46;20-2000 pg&#47;mL&#41; &#174;&#44; TGF-&#946;1 &#40;R &#38; D systems Quantikine ELISA&#174;&#59; 31&#46;20-2000 pg&#47;mL&#41;&#8901;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">An&#225;lisis estad&#237;stico</span><p id="par0045" class="elsevierStylePara elsevierViewall">Realizamos un estudio anal&#237;tico prospectivo no controlado antes-despu&#233;s&#46; Las variables recogidas fueron analizadas por el programa estad&#237;stico SPSS-21&#46; El an&#225;lisis se hizo considerando las tres evaluaciones bioqu&#237;micas de los pacientes &#40;basal&#44; uno y cuatro meses&#41;&#46; Las variables dimensionales se muestran como promedio<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>desviaci&#243;n est&#225;ndar &#40;DE&#41;&#46; Las variables nominales se muestran como n&#250;meros o porcentajes&#46; Las diferencias intragrupo fueron analizadas mediante <span class="elsevierStyleItalic">ANOVA</span> one way para muestras repetidas<span class="elsevierStyleItalic">&#46;</span> Se consider&#243; como resultado significativo un valor p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Medidas de seguridad y consideraciones &#233;ticas</span><p id="par0050" class="elsevierStylePara elsevierViewall">El presente estudio es considerado categor&#237;a II&#44; con riesgo m&#237;nimo&#46; En cada visita se indag&#243; sobre la presencia de eventos adversos tomando las medidas oportunas&#46; Se obtuvo consentimiento informado por parte de los pacientes<span class="elsevierStyleItalic">&#46;</span> La recogida de datos se realiz&#243; respetando la confidencialidad del paciente seg&#250;n la Ley de Protecci&#243;n de Datos de Car&#225;cter Personal y se respetaron los aspectos &#233;ticos de la investigaci&#243;n en seres humanos en Espa&#241;a&#46;</p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Resultados</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Descripci&#243;n de la cohorte</span><p id="par0055" class="elsevierStylePara elsevierViewall">Seleccionamos 46 pacientes&#58; 38 hombres &#40;82&#37;&#41; y 8 &#40;18&#37;&#41; mujeres&#44; con una edad media de 73 a&#241;os&#46; Los porcentajes seg&#250;n estadificaci&#243;n de ERC y etiolog&#237;a se muestran en la <a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#46; En cuanto a los tratamientos farmacol&#243;gicos 7 pacientes &#40;15&#37;&#41; tomaban previamente calcidiol &#40;periodo de lavado durante un mes previo al inicio del estudio&#41;&#44; 6 pacientes &#40;13&#37;&#41; estaban en tratamiento con captores del f&#243;sforo y 33 pacientes &#40;71&#44;8&#37;&#41; ten&#237;an prescrito inhibidores del sistema renina angiotensina aldosterona &#40;SRAA&#41;&#46; Ninguno de ellos presentaba tratamiento concomitante con cinacalcet&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Efecto de paricalcitol sobre las variables bioqu&#237;micas generales&#44; tasa de filtrado glomerular y proteinuria</span><p id="par0060" class="elsevierStylePara elsevierViewall">Los cambios experimentados&#44; tras la administraci&#243;n de PRCT&#44; sobre las variables hemoglobina&#44; hierro&#44; saturaci&#243;n de trasferrina&#44; CO2 total&#44; alb&#250;mina&#44; prealb&#250;mina&#44; perfil hep&#225;tico y lip&#237;dico no mostraron cambios significativos&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">La proteinuria no vari&#243; significativamente &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;299&#41;&#59; tampoco se produjo descenso significativo &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;766&#41; entre los pacientes que no presentaban tratamiento con inhibidores del SRAA &#40;28&#44;2&#37;&#41;&#46; S&#237; se produjo un aumento de creatinina significativo &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;007&#41; y cercano a la significaci&#243;n estad&#237;stica en la TFG &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;053&#41;&#59; ante estos datos subdividimos a los pacientes seg&#250;n grado de ERC catalog&#225;ndola como grave si TFG<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>ml&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span> &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>25&#41; o moderada si TFG<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>ml&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span> &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>21&#41;&#46; En los pacientes con ERC grave se produjo un descenso significativo de la TFG &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;002&#41;&#59; sin embargo&#44; entre los pacientes con ERC moderada&#44; no hubo significaci&#243;n estad&#237;stica &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;652&#41;&#46; Estos datos los mostramos en la <a class="elsevierStyleCrossRef" href="#tbl0010">tabla 2</a>&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Efecto de PRCT sobre la EOM-ERC</span><p id="par0070" class="elsevierStylePara elsevierViewall">Los marcadores cl&#225;sicos de la EOM-ERC como Ca y P no se vieron modificados &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;112&#44; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;066 respectivamente&#41;&#46; No hubo aumentos de Ca por encima<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>10&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dL ni de P<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>5&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dL&#44; por lo que no hubo que modificar la pauta de captores del P ni dosis de PRCT&#46; S&#237; se observ&#243; un descenso significativo de PTHi &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;02&#41;&#59; no obstante&#44; los valores de PTHi se mantuvieron en rango seg&#250;n estadificaci&#243;n en todos los pacientes &#40;Gu&#237;as SEN&#41; por lo que no hubo que suspender PRCT en ning&#250;n paciente&#46; Tambi&#233;n observamos un aumento de calcidiol significativo &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;010&#41;&#46; Datos desglosados en la <a class="elsevierStyleCrossRef" href="#tbl0015">tabla 3</a>&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">En cuanto a los par&#225;metros m&#225;s novedosos de la EOM-ERC &#40;<a class="elsevierStyleCrossRef" href="#fig0010">fig&#46; 2</a>&#41;&#44; iFGF-23 no se modific&#243; significativamente a lo largo del estudio &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;577&#41;&#59; tampoco entre los pacientes en tratamiento con captores del P &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>6&#59; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;125&#41;&#46; Calculamos la diferencia de medias al finalizar el estudio &#40;t de Student para muestras independientes&#41; entre pacientes con o sin captores del P&#44; el resultado no alcanz&#243; la significaci&#243;n estad&#237;stica &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;953&#44; con una diferencia de medias de 2&#44;48&#41;&#46; Se produjo un aumento significativo de los niveles de Klotho &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Efectos de PRCT sobre par&#225;metros relacionados con inflamaci&#243;n&#44; fibrosis y calcificaci&#243;n vascular</span><p id="par0080" class="elsevierStylePara elsevierViewall">No apreciamos cambios estad&#237;sticamente significativos en los niveles de PCR&#44; aunque la tendencia fue descendente&#46; IL6 y TNF-&#945; descendieron de forma significativa tras el uso de PRCT&#58; IL6 &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y TNF-&#945; &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;005&#41;&#46; IL10&#44; par&#225;metro antiinflamatorio&#44; aument&#243; significativamente &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46; En cuanto a par&#225;metros relacionados con la fibrosis y calcificaci&#243;n vascular&#44; observamos aumento significativo de Ft-A &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y BMP-7 &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y descenso de TGF-&#946;1 &#40;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46; Datos mostrados en la <a class="elsevierStyleCrossRef" href="#tbl0020">tabla 4</a> y <a class="elsevierStyleCrossRef" href="#fig0010">figura 2</a>&#46;</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Efectos adversos</span><p id="par0085" class="elsevierStylePara elsevierViewall">Durante el estudio no se produjeron reacciones adversas al medicamento&#44; ni cambios en el tratamiento&#46; No se produjeron ingresos ni eventos cardiovasculares&#46;</p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Discusi&#243;n</span><p id="par0090" class="elsevierStylePara elsevierViewall">En nuestro estudio los pacientes presentaban una mejor&#237;a de par&#225;metros relacionados con los procesos inflamatorio&#44; fibr&#243;tico y de calcificaci&#243;n vascular&#46; El impacto sobre marcadores de EOM-ERC muestran estabilidad en variables como Ca&#44; P&#44; FGF-23 y mejor&#237;a en otros como Klotho o PTH&#46; La EOM-ERC y la inflamaci&#243;n son determinantes en el inicio y la progresi&#243;n de la ERC y del RCV en estos enfermos<a class="elsevierStyleCrossRefs" href="#bib0335"><span class="elsevierStyleSup">15&#44;16</span></a>&#46; PRCT ha demostrado&#44; en m&#250;ltiples estudios experimentales&#44; su perfil seguro y beneficioso para regular la EOM-ERC y marcadores inflamatorios en la ERC sin agravar el proceso renal<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">17&#44;18</span></a>&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">En diferentes estudios se ha evaluado el efecto sobre la funci&#243;n renal y proteinuria de PRCT&#46; El estudio VITAL<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">19</span></a> demostr&#243;&#44; en pacientes diab&#233;ticos tipo 2&#44; una reducci&#243;n de proteinuria significativa a dosis de 2 ug&#47;d&#237;a de PRCT&#46; Similares resultados mostr&#243; el estudio de Agarwal et al&#46;<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">20</span></a> en pacientes con ERC EIII-IV&#46; El efecto antiprotein&#250;rico de PRCT&#44; y vitamina D activa&#44; tiene relaci&#243;n con la regulaci&#243;n del proceso proliferativo y fibr&#243;tico<a class="elsevierStyleCrossRefs" href="#bib0365"><span class="elsevierStyleSup">21&#44;22</span></a> y bloqueo del SRAA<a class="elsevierStyleCrossRefs" href="#bib0355"><span class="elsevierStyleSup">19&#44;23</span></a>&#59; la inhibici&#243;n farmacol&#243;gica de este eje puede condicionar que haya que aumentar la dosis de PRCT para conseguir el descenso de proteinuria&#46; En nuestro estudio no obtuvimos diferencias significativas en la evoluci&#243;n de la proteinuria&#44; tal vez debido al amplio uso de los inhibidores del SRAA &#40;71&#44;8&#37;&#41;&#46; En cuanto a la TFG&#44; no obtuvimos datos estad&#237;sticos significativos aunque s&#237; una tendencia al descenso tal vez debido al deterioro significativo que mostraban los enfermos con TFG<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>ml&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span>&#46; En cuanto al aumento significativo de Cr podr&#237;a estar en relaci&#243;n a la influencia de variables externas como sexo&#44; edad&#44; masa muscular y estado nutricional sobre esta variable&#46; Podr&#237;amos concluir que la activaci&#243;n del receptor de vitamina D con PRCT mantiene la TFG estable&#44; coincidiendo con otros estudios<a class="elsevierStyleCrossRefs" href="#bib0380"><span class="elsevierStyleSup">24&#44;25</span></a>&#46; Este efecto de PRCT podr&#237;a conllevar la atenuaci&#243;n sobre el da&#241;o glomerular&#44; tubulointersticial y endotelial que ha demostrado en ensayos experimentales mediante efectos antiinflamatorios<a class="elsevierStyleCrossRefs" href="#bib0390"><span class="elsevierStyleSup">26&#44;27</span></a>&#44; antifibr&#243;ticos<a class="elsevierStyleCrossRef" href="#bib0400"><span class="elsevierStyleSup">28</span></a> y antiprotein&#250;ricos<a class="elsevierStyleCrossRefs" href="#bib0355"><span class="elsevierStyleSup">19&#44;20</span></a> como comentaremos a posteriori&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">Como era de esperar&#44; PRCT redujo PTHi de manera significativa coincidiendo con diversos estudios<a class="elsevierStyleCrossRefs" href="#bib0405"><span class="elsevierStyleSup">29&#44;30</span></a>&#46; Evidenciamos estabilidad en los niveles de Ca y P&#44; aunque en el caso del P la tendencia era al alza&#46; Este efecto menos hipercalcemiante e hiperfosfatemiante de PRCT viene determinado al producirse menos calbindina intestinal y a su menor afinidad por los receptores intestinales de vitamina D<a class="elsevierStyleCrossRef" href="#bib0415"><span class="elsevierStyleSup">31</span></a>&#44; lo cual podr&#237;a influir en la g&#233;nesis de la calcificaci&#243;n vascular&#46; No hay un claro mecanismo del aumento de calcidiol en nuestro estudio&#59; tal vez sea debido a la estabilidad de FGF-23 &#40;estimulante de la 24-hidroxilasa que inactiva calcidiol&#41; que obtuvimos&#46; En este sentido&#44; y siguiendo en el marco de la EOM&#44; el efecto de PRCT sobre marcadores como FGF-23 y Klotho ser&#237;a relevante dado que ambos par&#225;metros podr&#237;an modular la calcificaci&#243;n vascular&#44; el estado inflamatorio y la funci&#243;n renal&#46; En el caso de Klotho obtuvimos un aumento significativo de sus niveles s&#233;ricos&#59; Klotho posee efectos beneficiosos a nivel mioc&#225;rdico y la hipertrofia ventricular izquierda<a class="elsevierStyleCrossRefs" href="#bib0425"><span class="elsevierStyleSup">33&#44;34</span></a>&#44; antiinflamatorios<a class="elsevierStyleCrossRefs" href="#bib0420"><span class="elsevierStyleSup">32&#44;36</span></a> &#40;descenso de los niveles de IL6 y 18&#41;&#44; antifibr&#243;ticos<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">35</span></a> &#40;descenso de TGF-&#946;&#41; y efectos antiapoptoicos<a class="elsevierStyleCrossRef" href="#bib0445"><span class="elsevierStyleSup">37</span></a> que podr&#237;an influir en la g&#233;nesis de la calcificaci&#243;n vascular<a class="elsevierStyleCrossRefs" href="#bib0420"><span class="elsevierStyleSup">32&#44;36</span></a>&#46; PRCT ha demostrado regular al alza los niveles de Klotho en diversos estudios como el de Lau et al&#46;<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">11</span></a> donde el tratamiento de PRCT y calcitriol&#44; en ratones ur&#233;micos con calcificaci&#243;n vascular&#44; aument&#243; de forma significativa los niveles de Klotho urinarios y s&#233;ricos&#46; En lo referente a los niveles FGF-23 nuestro estudio mostr&#243; resultados dispares frente a otros como el IMPACT<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">38</span></a> o PARADIGM<a class="elsevierStyleCrossRef" href="#bib0455"><span class="elsevierStyleSup">39</span></a> donde el uso de PRCT o calcitriol&#44; en pacientes en hemodi&#225;lisis&#44; aumentaba FGF-23&#46; Esta discordancia podr&#237;a ser debida a que nuestros pacientes no estaban incluidos en di&#225;lisis y se les presupone mayor funci&#243;n renal residual&#46; No hay duda de que el aumento de FGF-23 en la ERC se relaciona con la calcificaci&#243;n vascular&#44; aunque no como inductor<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">40</span></a>&#44; y con un aumento en la morbimortalidad vascular<a class="elsevierStyleCrossRefs" href="#bib0465"><span class="elsevierStyleSup">41&#8211;43</span></a>&#46; FGF-23 suprime los niveles de calcitriol<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">3&#44;6</span></a> y de Ft-A<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">41</span></a> &#40;potente anticalcificante&#41;&#44; provoca disfunci&#243;n endotelial&#44; desarrollo de hipertrofia ventricular izquierda y proteinuria<a class="elsevierStyleCrossRefs" href="#bib0465"><span class="elsevierStyleSup">41&#44;42</span></a>&#46; Muchos de estos mecanismos procalcificantes de FGF-23 tienen como agravante el ambiente inflamatorio de la ERC<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">3&#44;44</span></a> que es estimulado por FGF-23 induciendo el aumento de IL6 y TNF-&#945; <a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">45</span></a>&#46; A su vez&#44; el propio estado inflamatorio regula al alza los niveles de FGF-23&#58; TNF-&#945; y NF-&#954;B pueden inhibir la matriz &#243;sea y aumentar la producci&#243;n de FGF-23 en el osteocito<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">45</span></a>&#46; Adem&#225;s el estado proinflamatorio y fibr&#243;tico de la ERC modula los niveles de Klotho a la baja<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">36</span></a>&#46;</p><p id="par0105" class="elsevierStylePara elsevierViewall">La propia inflamaci&#243;n es un target terap&#233;utico en la ERC donde PRCT ha demostrado sus efectos beneficiosos<a class="elsevierStyleCrossRefs" href="#bib0325"><span class="elsevierStyleSup">13&#44;14</span></a>&#46; Tras el uso de PRCT nuestros pacientes presentaban un efecto bioqu&#237;mico antiinflamatorio favorable al descender de manera significativamente los niveles de IL6 y TNF-&#945; y aumentar IL10&#44; mediado tal vez por el aumento de Klotho y estabilidad de FGF-23 o por un efecto directo del f&#225;rmaco&#46; Donate et al&#46;<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">22</span></a> coinciden con nuestros resultados&#59; estos autores demostraron en pacientes con ERC y elevaci&#243;n de PTH &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>8&#59; estadiajes IIIB-IV&#41; que el tratamiento con PRCT provoc&#243; un descenso significativo de IL6 y TNF-&#945;&#46; El efecto antiinflamatorio de PRCT podr&#237;a estar condicionado por la disminuci&#243;n de la producci&#243;n de citoquinas por las c&#233;lulas T<a class="elsevierStyleCrossRefs" href="#bib0390"><span class="elsevierStyleSup">26&#44;27</span></a>&#46; Estos efectos antiinflamatorios de PRCT podr&#237;an influir sobre par&#225;metros anticalcificantes como Ft-A o BMP-7 &#40;descendidos en pacientes con ERC<a class="elsevierStyleCrossRefs" href="#bib0300"><span class="elsevierStyleSup">8&#44;46</span></a>&#41;&#44; y fibr&#243;ticos como TGF-&#946; &#40;aumentado en ERC&#41;&#46; El aumento de Ft-A tras el uso de PRCT que obtuvimos podr&#237;a mejorar el perfil procalcificante&#44; al igual que los resultados que obtuvimos sobre BMP-7 que&#44; adem&#225;s de sus efectos anticalcificantes<a class="elsevierStyleCrossRefs" href="#bib0495"><span class="elsevierStyleSup">47&#44;48</span></a> &#40;inhibe el cotransportador Na&#47;Pi de las CMLV&#41;&#44; promueve la formaci&#243;n &#243;sea y presenta efectos antiinflamatorios<a class="elsevierStyleCrossRefs" href="#bib0495"><span class="elsevierStyleSup">47&#44;49</span></a>&#46; El caso de TGF-&#946; es el contrario a BMP-7&#59; su descenso&#44; significativo en nuestro estudio&#44; podr&#237;a implicar nefroprotecci&#243;n y una atenuaci&#243;n del da&#241;o vascular<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">50</span></a> al disminuir la migraci&#243;n de stem cells mesenquimales osteoprogenitoras a las zonas da&#241;adas<a class="elsevierStyleCrossRef" href="#bib0515"><span class="elsevierStyleSup">51</span></a> promovida por TGF-&#946; y disminuyendo la apoptosis&#44; proliferaci&#243;n y diferenciaci&#243;n celular<a class="elsevierStyleCrossRef" href="#bib0520"><span class="elsevierStyleSup">52</span></a>&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">Nuestro estudio tiene limitaciones&#59; los pacientes son controles de s&#237; mismos&#44; no poseemos grupo placebo&#44; el tiempo de observaci&#243;n es corto y nuestra cohorte peque&#241;a lo cual puede conllevar alteraciones en la interpretaci&#243;n de resultados&#46; Adem&#225;s&#44; no diferenciamos los meses de inclusi&#243;n de los pacientes que podr&#237;a influir en los niveles de calcidiol al variar estacionalmente&#46; Basamos nuestros resultados en marcadores sangu&#237;neos y no en modelos experimentales de lesi&#243;n vascular&#59; as&#237; mismo no hemos aportado datos sobre otras mol&#233;culas como RANK-L &#40;ligando de r<span class="elsevierStyleItalic">eceptor</span>&#160;activador del factor nuclear &#954; beta&#41;&#44; osteopontina u osteoprotegerina&#46; Como contrapunto los par&#225;metros analizados abarcan una importante influencia en la calcificaci&#243;n vascular&#44; la inflamaci&#243;n y la fibrosis con una posible regulaci&#243;n favorable tras el tratamiento con PRCT&#46;</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Conclusiones</span><p id="par0115" class="elsevierStylePara elsevierViewall">El tratamiento con PRCT&#44; en el paciente renal sin di&#225;lisis&#44; parece ser beneficioso en la regulaci&#243;n de par&#225;metros inflamatorios&#44; fibr&#243;ticos y anticalcificantes&#59; as&#237; como sobre marcadores cl&#225;sicos y no cl&#225;sicos de la EOM-ERC preservando la funci&#243;n renal&#46; No existe un marcador que valore los efectos pleiotr&#243;picos de PRCT en la enfermedad renal&#46; Los marcadores elegidos en nuestro estudio podr&#237;an indicarnos su efecto en la enfermedad &#243;seo-mineral renal y&#44; en concreto&#44; en el proceso de calcificaci&#243;n vascular&#46;</p><p id="par0120" class="elsevierStylePara elsevierViewall">Los datos obtenidos podr&#237;an indicar un efecto modulador de PRCT positivos sobre marcadores relacionados con la calcificaci&#243;n vascular&#44; el estado inflamatorio y fibr&#243;tico de la ERC&#46;</p><p id="par0125" class="elsevierStylePara elsevierViewall">El abordaje terap&#233;utico de los AVDR sigue sin ser explorado en la cl&#237;nica de los pacientes con ERC&#44; quedando relegado como uso exclusivo en el hiperparatiroidismo secundario y sin la realizaci&#243;n de ensayos cl&#237;nicos con expectativas m&#225;s amplias en los &#250;ltimos a&#241;os en la pr&#225;ctica cl&#237;nica&#46; Esto deja un campo a&#250;n por explorar especialmente en lo que ata&#241;e a la calcificaci&#243;n vascular en pacientes con enfermedad renal cr&#243;nica&#46;</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Conflicto de intereses</span><p id="par0130" class="elsevierStylePara elsevierViewall">Los autores declaran no tener ning&#250;n conflicto de intereses&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:11 [
        0 => array:3 [
          "identificador" => "xres1312458"
          "titulo" => "Resumen"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Antecedentes"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Objetivos"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Material y m&#233;todos"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Resultados"
            ]
            4 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1211416"
          "titulo" => "Palabras clave"
        ]
        2 => array:3 [
          "identificador" => "xres1312457"
          "titulo" => "Abstract"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Backward"
            ]
            1 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Objective"
            ]
            2 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Material and methods"
            ]
            3 => array:2 [
              "identificador" => "abst0045"
              "titulo" => "Results"
            ]
            4 => array:2 [
              "identificador" => "abst0050"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1211415"
          "titulo" => "Keywords"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introducci&#243;n"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Material y m&#233;todos"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Pacientes"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Determinaciones"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "An&#225;lisis estad&#237;stico"
            ]
            3 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Medidas de seguridad y consideraciones &#233;ticas"
            ]
          ]
        ]
        6 => array:3 [
          "identificador" => "sec0035"
          "titulo" => "Resultados"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Descripci&#243;n de la cohorte"
            ]
            1 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Efecto de paricalcitol sobre las variables bioqu&#237;micas generales&#44; tasa de filtrado glomerular y proteinuria"
            ]
            2 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Efecto de PRCT sobre la EOM-ERC"
            ]
            3 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Efectos de PRCT sobre par&#225;metros relacionados con inflamaci&#243;n&#44; fibrosis y calcificaci&#243;n vascular"
            ]
            4 => array:2 [
              "identificador" => "sec0060"
              "titulo" => "Efectos adversos"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0065"
          "titulo" => "Discusi&#243;n"
        ]
        8 => array:2 [
          "identificador" => "sec0070"
          "titulo" => "Conclusiones"
        ]
        9 => array:2 [
          "identificador" => "sec0075"
          "titulo" => "Conflicto de intereses"
        ]
        10 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2019-02-16"
    "fechaAceptado" => "2019-08-23"
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1211416"
          "palabras" => array:6 [
            0 => "Paricalcitol"
            1 => "FGF-23"
            2 => "Klotho"
            3 => "Inflamaci&#243;n"
            4 => "Fetu&#237;na A"
            5 => "Estado ur&#233;mico&#46;"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1211415"
          "palabras" => array:6 [
            0 => "Paricalcitol"
            1 => "FGF-23"
            2 => "Klotho"
            3 => "Inflammation"
            4 => "Fetuin-A"
            5 => "Uremic status&#46;"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Antecedentes</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">La principal causa de morbimortalidad en el paciente con enfermedad renal cr&#243;nica &#40;ERC&#41; es la cardiovascular&#46; La inflamaci&#243;n y las alteraciones en el metabolismo &#243;seo-mineral en estos pacientes conllevan aumento del riesgo cardiovascular&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objetivos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Valorar el papel de paricalcitol sobre distintos par&#225;metros s&#233;ricos relacionados con inflamaci&#243;n&#44; fibrosis y enfermedad &#243;seo-mineral en la ERC&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Material y m&#233;todos</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Estudio prospectivo&#44; no controlado en 46 pacientes con ERC estadios III-V sin di&#225;lisis&#44; con niveles elevados de paratohormona&#44; seg&#250;n su estadio de ERC&#44; por lo que se introdujo tratamiento con el an&#225;logo de vitamina D paricalcitol&#46; Durante 4 meses de tratamiento valoramos los par&#225;metros cl&#225;sicos y novedosos del metabolismo &#243;seo-mineral en suero &#40;calcio&#44; f&#243;sforo&#44; paratohormona&#44; factor de crecimiento fibrobl&#225;stico-23 &#91;FGF-23&#93;&#44; Klotho y calcidiol&#41; y par&#225;metros relacionados con el proceso de inflamaci&#243;n-fibrosis y anticalcificantes &#40;interleucina-6 y 10&#44; factor de necrosis tumoral alfa &#91;TNF-a&#93;&#44; factor de crecimiento transformante beta &#91;TGF-b&#93;&#44; prote&#237;na &#243;sea morfog&#233;nica-7 &#91;BMP-7&#93;&#44; y fetu&#237;na-A&#41;&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Resultados</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Tras el uso de paricalcitol los niveles de Klotho aumentaron &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y los de FGF-23 se mantuvieron estables al igual que los de calcio y f&#243;sforo&#59; calcidiol aument&#243; de forma significativa &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;010&#41; y paratohormona descendi&#243; &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;002&#41;&#46; Los par&#225;metros de inflamaci&#243;n&#44; fibrosis y calcificaci&#243;n mostraron una regulaci&#243;n benigna con descenso significativo de interleucina-6 &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#44; TNF-&#945; &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;005&#41; y TGF-&#946; &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; y aumento de BMP-7 &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#44; fetu&#237;na-A &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41; e interleucina-10 &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&#41;&#46; El filtrado glomerular y la proteinuria se mantuvieron estables&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusiones</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">El tratamiento con paricalcitol en el paciente renal sin di&#225;lisis parece ser beneficioso en la regulaci&#243;n de los par&#225;metros inflamatorios y anticalcificantes&#44; preservando la funci&#243;n renal y el eje &#243;seo-mineral&#46; Los marcadores elegidos en nuestro estudio podr&#237;an indicarnos un efecto positivo de paricalcitol a nivel vascular&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Antecedentes"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Objetivos"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Material y m&#233;todos"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Resultados"
          ]
          4 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Backward</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Cardiovascular events are the major cause of morbidity and mortality in patients with chronic kidney disease &#40;CKD&#41;&#46; Inflammation and mineral-bone disorder are pathological conditions that have been associated with an increased cardiovascular risk&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objective</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Show paricalcitol regulation overinflammatory&#44; fibrotic and mineral disorder parameters in CKD&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Material and methods</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Prospective Study in 46 CKD stages III-V patients without dialysis patients whith elevated parathormone in which we introduced paricalcitol&#46; We evaluated classic and newest mineral and bone metabolism serum parameters &#40;calcium&#44; phosphorus&#44; parathormone&#44; fibroblast growth factor-23 &#91;FGF-23&#93;&#44; Klotho&#44; calcidiol&#41;&#44; inflammatory-fibrosis and anticalcifying parameters &#40;interleukin-6 and 10&#44; tumor necrosis factor-a &#91;TNF- &#945;&#93;&#44; transforming growth factor-b &#91;TGF-&#946;&#93;&#44;bone morphogenic protein-7 &#91;BMP-7&#93; and fetuin-A&#41; for four months&#46;</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Results</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">At the end of study soluble Klotho increased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41;&#44; FGF-23 remained stable&#44; calcium and phosphorus levels were not increased&#44; calcidiol increased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;010&#41; and PTH decreased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleMonospace">&#46;</span>002&#41;&#46; Inflammation-fibrosis and calcification parameters showed positive regulation after paricalcitol treatment&#58; interleukin-6 decreased significantly &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41; and also TNF-&#945; did &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;005&#41;&#44; on the contrary&#44; interleukin-10 and fetuin-A increased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001 for both&#41;&#46; Anti-fibrosis marker BMP-7 increased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41; and TGF-b decreased &#40;p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#46;001&#41;&#46; We did not find significant changes in renal function&#46;</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusions</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Paricalcitol treatment might be profitable in regulating inflammatory and anticalcificant parameters&#44; unmodified calcium or phosphorus seric levels and preserving kidney function in renal patients with no dialysis&#46; Our selected parameters could indicate paricalcitol effects in mineral and endothelial disorder related to renal disease&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Backward"
          ]
          1 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Objective"
          ]
          2 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Material and methods"
          ]
          3 => array:2 [
            "identificador" => "abst0045"
            "titulo" => "Results"
          ]
          4 => array:2 [
            "identificador" => "abst0050"
            "titulo" => "Conclusions"
          ]
        ]
      ]
    ]
    "multimedia" => array:6 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1426
            "Ancho" => 2091
            "Tamanyo" => 250652
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Esquema de investigaci&#243;n cl&#237;nica&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 2889
            "Ancho" => 1488
            "Tamanyo" => 151311
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">A y B&#41; Evoluci&#243;n de los par&#225;metros m&#225;s novedosos de EOM-ERC &#40;Klotho y FGF-23&#41; a lo largo del estudio&#46;C-H&#41; Evoluci&#243;n de los par&#225;metros relacionados con inflamaci&#243;n&#44; fibrosis y calcificaci&#243;n vascular a lo largo del estudio&#46; Valores expresados en medias aritm&#233;ticas&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Los porcentajes en cada estadificaci&#243;n se refieren al n&#250;mero de enfermos en cada uno de ellos&#46;</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">AEE&#58; agente estimulante de la eritropoyesis&#59; DM&#58; diabetes mellitus&#59; GNII&#58; glomerulonefritis&#59; NAE&#58; nefroangioesclerosis&#59; SRAA&#58; sistema renina angiotensina aldosterona&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ERC Estadio III&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ERC Estadio IV&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ERC Estadio V&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">N&#46;&#176; Pacientes</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">46 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19 &#40;41&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23 &#40;50&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4 &#40;8&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="5" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="5" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Etiolog&#237;a</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>DM&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">18 &#40;39&#44;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7 &#40;36&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8 &#40;34&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;75&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>NAE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23 &#40;50&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10 &#40;52&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12 &#40;52&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;25&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>GNII&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5 &#40;11&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;10&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="5" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="5" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">F&#225;rmacos</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Captores del f&#243;sforo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6 &#40;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;5&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;50&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>SRAA inhibidores&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">33 &#40;71&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">14 &#40;73&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">16 &#40;69&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;75&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>AEE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">11 &#40;24&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;5&#44;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8 &#40;34&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;50&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Calcidiol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7 &#40;15&#44;21&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;10&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4 &#40;17&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;25&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2249488.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas etiol&#243;gicas y farmacol&#243;gicas de los pacientes incluidos en el estudio seg&#250;n grado de ERC al inicio del estudio</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Tabla 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Funci&#243;n renal y proteinuria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rango normal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media basal<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 1 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 4 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">p valor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Creatinina &#40;mg&#47;dL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;5-1&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#44;54<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;05&#40;1&#44;3-6&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#44;56<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;08&#40;1&#44;2-6&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#44;69<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;18&#40;1&#44;1-7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;007</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TFG MDRD 4 &#40;mL&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Positivo&#60;<span class="elsevierStyleHsp" style=""></span>60&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;87<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#44;8&#40;8&#44;2-59&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;52<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#44;70&#40;7&#44;4-59&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">27&#44;81<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#44;31&#40;6&#44;3-63&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;053&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#62;<span class="elsevierStyleHsp" style=""></span>30 mL&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">36&#44;11<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>7&#44;17&#40;24&#44;2-59&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;21<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#44;77&#40;30&#44;2-59&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">36&#44;69<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#44;62&#40;30&#44;3-63&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;652&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;<span class="elsevierStyleHsp" style=""></span>30 mL&#47;min&#47;1&#44;73m<span class="elsevierStyleSup">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22&#44;32<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>6&#44;57&#40;8&#44;2-29&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;78<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#44;98&#40;7&#44;4-29&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">20&#44;55<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#44;98&#40;6&#44;3-28&#44;6&#44;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;002</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Proteinuria &#40;mg&#47;24h&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0-15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1377&#44;81<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2095&#44;39&#40;63-9540&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1035&#44;43<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1687&#44;85&#40;48-9240&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1167&#44;61<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1560&#44;47&#40;83&#44;6-7463&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;299&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2249489.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de las variables de funci&#243;n renal y proteinuria durante el estudio</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Tabla 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media basal<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 1 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 4 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">p valor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Ca &#40;mg&#47;dL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#44;1-10&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&#44;25<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;66&#40;8-12&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&#44;39<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;54&#40;8&#44;1-10&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&#44;39<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;52&#40;8&#44;5-10&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;112&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">P &#40;mg&#47;dL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#44;7-5&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#44;57<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;80&#40;2&#44;2-5&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#44;72<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;78&#40;1&#44;8-5&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#44;78<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;69&#40;2&#44;2-5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;066&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">PTHi &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">15-65&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">158&#44;17<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>90&#44;23&#40;75-472&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">110&#44;34<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>67&#44;6&#40;75-307&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">119<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>87&#44;79&#40;40-368&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;002</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Calcidiol &#40;ng&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#62;<span class="elsevierStyleHsp" style=""></span>30&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">21&#44;35<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>8&#44;59&#40;8&#44;2-46&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22&#44;22<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#44;17&#40;5-53&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">26&#44;22<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>13&#44;15&#40;10-35&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;010</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">iFGF23 &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&#44;9-2400&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">112&#44;80<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>81&#44;12&#40;17&#44;1-<span class="elsevierStyleItalic">359</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">110&#44;96<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>98&#44;86&#40;17-583&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">106&#44;60<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>95&#44;51&#40;25-<span class="elsevierStyleItalic">437</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;577&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Klotho &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7&#44;8-500&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">218&#44;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>113&#44;62&#40;45&#44;7-407&#44;6<span class="elsevierStyleItalic">&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">245&#44;53<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>126&#44;48&#40;60&#44;3-518&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">284&#44;60<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>138&#44;17&#40;54&#44;6-565&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2249490.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de las variables bioqu&#237;micas de EOM-ERC durante el estudio</p>"
        ]
      ]
      5 => array:8 [
        "identificador" => "tbl0020"
        "etiqueta" => "Tabla 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at4"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media basal<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 1 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Media 4 mes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>DERango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">p valor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">PCR &#40;mg&#47;dL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;00-0&#44;80&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#44;13 &#40;&#177;3&#44;24&#41;&#40;0&#44;0-21&#44;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;85 &#40;&#177;1&#44;71&#41;&#40;0&#44;0-7&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;70 &#40;&#177;1&#44;45&#41;&#40;0&#44;0-9&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;182&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">IL6 &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;156-10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">32&#44;9 &#40;&#177;16&#44;40&#41;&#40;10&#44;1-92&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">30 &#40;&#177;15&#44;49&#41;&#40;10&#44;1-75&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">23&#44;10 &#40;&#177;9&#44;94&#41;&#40;6&#44;2-48&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">IL10 &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;78-50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12&#44;80 &#40;&#177;6&#44;10&#41;&#40;4&#44;6-35&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">18&#44;39 &#40;&#177;8&#44;09&#41;&#40;3&#44;6-53&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19&#44;60 &#40;&#177;7&#44;91&#41;&#40;8&#44;9-37&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TNF-&#945; &#40;pg&#47;mL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;5-32&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">13&#44;70 &#40;&#177;12&#44;02&#41;&#40;0&#44;9-70&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12&#44;11 &#40;&#177;10&#44;90&#41;&#40;1&#44;6-56&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#44;80 &#40;&#177;6&#44;28&#41;&#40;2&#44;2-34&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">0&#44;005</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fetu&#237;na A g&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;698-2&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;20<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;08&#40;0&#44;1-0&#44;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;23<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;10&#40;0&#44;1-0&#44;39&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;27<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#44;16&#40;0&#44;1-0&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">&#60;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">0&#44;0001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">TGF-&#946;1 pg&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31&#44;20-2000&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6584&#44;91<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3468&#44;662013&#44;8-15892&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6224&#44;42<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3462&#44;861782&#44;2-14805&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5631&#44;01<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3167&#44;171892&#44;2-14587&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">&#60;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">0&#44;0001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">BMP-7 pg&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31&#44;20-2000&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#44;55<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;222&#44;58-7&#44;12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#44;95<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;412&#44;56-7&#44;76&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#44;39<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;522&#44;67-8&#44;12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleBold">&#60;</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">0&#44;0001</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2249487.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">Evoluci&#243;n de los par&#225;metros inflamatorios&#44; fibrosis y calcificaci&#243;n vascular</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:52 [
            0 => array:3 [
              "identificador" => "bib0265"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recomendaciones de la Sociedad Espa&#241;ola de Nefrolog&#237;a para el manejo de las alteraciones del metabolismo &#243;seo-mineral en los pacientes con enfermedad renal cr&#243;nica"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;V&#46; Torregrosa"
                            1 => "J&#46; Bover Sanju&#225;n"
                            2 => "J&#46; Cannata And&#237;a"
                            3 => "F&#46; Caravaca"
                            4 => "V&#46; Lorenzo"
                            5 => "A&#46;L&#46; Mart&#237;n de Francisco"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3265/Nefrologia.pre2011.Jan.10816"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nefrologia&#46;"
                        "fecha" => "2011"
                        "volumen" => "31"
                        "paginaInicial" => "3"
                        "paginaFinal" => "32"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21468161"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "KDIGO 2017 Clinical practice guideline update for the diagnosis&#44; evaluation&#44; prevention&#44; and treatment of chronic kidney disease&#8211;mineral and bone disorder &#40;CKD-MBD&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Isakova"
                            1 => "T&#46;L&#46; Nickolas"
                            2 => "M&#46; Denburg"
                            3 => "S&#46; Yarlagadda"
                            4 => "D&#46;E&#46; Weiner"
                            5 => "O&#46;M&#46; Guti&#233;rrez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Kidney Int Supplements&#46;"
                        "fecha" => "2017"
                        "paginaInicial" => "1"
                        "paginaFinal" => "59"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mechanistic insights into vascular calcification in CKD"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Shroff"
                            1 => "D&#46;A&#46; Long"
                            2 => "C&#46; Shanahan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2011121191"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2013"
                        "volumen" => "24"
                        "paginaInicial" => "179"
                        "paginaFinal" => "189"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23138485"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Update on chronic&#160;kidney disease&#160;mineral and bone disorder in cardiovascular&#160;disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46; Lunyera"
                            1 => "J&#46;J&#46; Scialla"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Semin Nephrol&#46;"
                        "fecha" => "2018"
                        "volumen" => "38"
                        "paginaInicial" => "542"
                        "paginaFinal" => "558"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Klotho deficiency causes vascular calcification in chronic kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;C&#46; Hu"
                            1 => "M&#46; Shi"
                            2 => "J&#46; Zhang"
                            3 => "H&#46; Quinones"
                            4 => "C&#46; Griffith"
                            5 => "M&#46; Kuro-o"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "124"
                        "paginaFinal" => "136"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Plasma Fetuin A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver diseas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Roos"
                            1 => "J&#46; Lutz"
                            2 => "H&#46; Salmhofer"
                            3 => "F&#46; Aslan"
                            4 => "C&#46;N&#46; Ercin"
                            5 => "F&#46; Ors"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2265.2012.04460.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clinical Endocrinology&#46;"
                        "fecha" => "2013"
                        "volumen" => "78"
                        "paginaInicial" => "712"
                        "paginaFinal" => "717"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22676641"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0295"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bone morphogenetic proteins in vascular calcification"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "K&#46; Hruska"
                            1 => "S&#46; Mathew"
                            2 => "G&#46; Saab"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/01.RES.00000175571.53833.6c"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circ Res&#46;"
                        "fecha" => "2005"
                        "volumen" => "97"
                        "paginaInicial" => "105"
                        "paginaFinal" => "114"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16037577"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0300"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The expanding spectrum of biological actions of vitamin D"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46; Rojas-Rivera"
                            1 => "C&#46; de La Piedra"
                            2 => "A&#46; Ramos"
                            3 => "A&#46; Ortiz"
                            4 => "J&#46; Egido"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfq313"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol&#46; Dial&#46; Transplant&#46;"
                        "fecha" => "2010"
                        "volumen" => "25"
                        "paginaInicial" => "2850"
                        "paginaFinal" => "2865"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20525641"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0305"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "receptor agonist increase Klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:7 [
                            0 => "W&#46;L&#46; Lau"
                            1 => "E&#46;M&#46; Leaf"
                            2 => "M&#46;C&#46; Hu"
                            3 => "M&#46;M&#46; Takeno"
                            4 => "M&#46; Kuro-o"
                            5 => "O&#46;W&#46; Moe"
                            6 => "D&#46; Vitamin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.2012.322"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2012"
                        "volumen" => "82"
                        "paginaInicial" => "1261"
                        "paginaFinal" => "1270"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22932118"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0310"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vitamin D attenuates endothelial dysfunction in uremic rats and maintains human endothelial stability"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Vila Cuenca"
                            1 => "E&#46; Ferrantelli"
                            2 => "E&#46; Meinster"
                            3 => "S&#46;M&#46; Pouw"
                            4 => "I&#46; Kova&#269;evi&#263;"
                            5 => "R&#46;X&#46; de Menezes"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/JAHA.118.760087"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Heart Assoc&#46;"
                        "fecha" => "2018"
                        "volumen" => "7"
                        "paginaInicial" => "e008776"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30371149"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0315"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Double treatment with paricalcitol-associated calcifediol and cardiovascular risk biomarkers in haemodialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Pi&#241;era"
                            1 => "M&#46;A&#46; Izquierdo"
                            2 => "L&#46;A&#46; Mart&#237;n de Francisco"
                            3 => "M&#46;T&#46; Garc&#237;a-Unzueta"
                            4 => "M&#46; L&#243;pez-Hoyos"
                            5 => "C&#46; Toyos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Nefrolog&#237;a&#46;"
                        "fecha" => "2013"
                        "volumen" => "18"
                        "paginaInicial" => "77"
                        "paginaFinal" => "84"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0320"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;J&#46; Izquierdo"
                            1 => "M&#46; Cavia"
                            2 => "P&#46; Mu&#241;iz"
                            3 => "A&#46;L&#46; de Francisco"
                            4 => "M&#46; Arias"
                            5 => "J&#46; Santos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "BMC Nephrology&#46;"
                        "fecha" => "2012"
                        "volumen" => "27"
                        "paginaInicial" => "159"
                        "paginaFinal" => "165"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0325"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Differential&#160;effects&#160;of&#160;vitamin D&#160;analogs&#160;on&#160;vascular calcification"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Card&#250;s"
                            1 => "S&#46; Panizo"
                            2 => "E&#46; Parisi"
                            3 => "E&#46; Fern&#225;ndez"
                            4 => "J&#46;M&#46; Valdivielso"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1359/jbmr.070305"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Bone Miner Res&#46;"
                        "fecha" => "2007"
                        "volumen" => "22"
                        "paginaInicial" => "860"
                        "paginaFinal" => "866"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17352647"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0330"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "High phosphate induces a pro-inflammatory response by vascular smooth muscle cells and modulation by vitamin D derivatives"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;M&#46; Mart&#237;nez-Moreno"
                            1 => "C&#46; Herencia"
                            2 => "A&#46;M&#46; de Oca"
                            3 => "J&#46;M&#46; D&#237;az-Tocados"
                            4 => "N&#46; Vergara"
                            5 => "M&#46;J&#46; G&#243;mez-Luna"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1042/CS20160807"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Sci&#46;"
                        "fecha" => "2017"
                        "volumen" => "131"
                        "paginaInicial" => "1449"
                        "paginaFinal" => "1463"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28442557"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0335"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Management of cardiovascular disease in patients with kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M&#46;R&#46; Kahn"
                            1 => "M&#46;J&#46; Robbins"
                            2 => "M&#46;C&#46; Kim"
                            3 => "V&#46; Fuster"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrcardio.2013.15"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat&#46; Rev&#46; Cardiol&#46;"
                        "fecha" => "2013"
                        "volumen" => "10"
                        "paginaInicial" => "261"
                        "paginaFinal" => "273"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23419899"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0340"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Associations of plasma 25 Hydroxyvitamin D and 1&#44;25-Dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Kendrick"
                            1 => "A&#46;K&#46; Cheung"
                            2 => "J&#46; Kaufman"
                            3 => "T&#46; Greene"
                            4 => "W&#46;L&#46; Roberts"
                            5 => "G&#46; Smits"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.ajkd.2012.04.014"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Kidney Dis&#46;"
                        "fecha" => "2012"
                        "volumen" => "60"
                        "paginaInicial" => "567"
                        "paginaFinal" => "575"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22621970"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0345"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Inflammation and oxidative stress in ESRD &#8211; the role of myeloperoxidase"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Y&#46; Maruyama"
                            1 => "B&#46; Lindholm"
                            2 => "P&#46; Stenvinkel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Nephrol&#46;"
                        "fecha" => "2004"
                        "volumen" => "17"
                        "paginaInicial" => "72"
                        "paginaFinal" => "76"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0350"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patient"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Capuano"
                            1 => "V&#46; Serio"
                            2 => "A&#46; Pota"
                            3 => "B&#46; Memoli"
                            4 => "V&#46;E&#46; Andreucci"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Nephrol&#46;"
                        "fecha" => "2009"
                        "volumen" => "22"
                        "paginaInicial" => "59"
                        "paginaFinal" => "68"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19229819"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0355"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Selective Vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes &#40;VITAL study&#41;&#58; a randomised controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Zeeuw"
                            1 => "R&#46; Agarwal"
                            2 => "M&#46; Amdahl"
                            3 => "P&#46; Audhya"
                            4 => "D Coyne"
                            5 => "T&#46; Garimella"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)61032-X"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet&#46;"
                        "fecha" => "2010"
                        "volumen" => "376"
                        "paginaInicial" => "1543"
                        "paginaFinal" => "1551"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21055801"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0360"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antiproteinuric effect of oral paricalcitol in chronic kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Agarwal"
                            1 => "M&#46; Acharya"
                            2 => "J&#46; Tian"
                            3 => "R&#46;L&#46; Hippensteel"
                            4 => "J&#46;Z&#46; Melnick"
                            5 => "P&#46; Qiu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1523-1755.2005.00755.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2005"
                        "volumen" => "68"
                        "paginaInicial" => "2823"
                        "paginaFinal" => "2828"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16316359"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0365"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Yanagisawa"
                            1 => "Y&#46; Yanagi"
                            2 => "Y&#46; Masuhiro"
                            3 => "M&#46; Suzawa"
                            4 => "M&#46; Watanabe"
                            5 => "K&#46; Kashiwagi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Science"
                        "fecha" => "1999"
                        "volumen" => "283"
                        "paginaInicial" => "1317"
                        "paginaFinal" => "1321"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0370"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Selective Vitamin D receptor activation as anti-inflammatory target in chronic kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Donate"
                            1 => "V&#46; Dom&#237;nguez"
                            2 => "M&#46;L&#46; M&#233;ndez"
                            3 => "M&#46; Muros-de-Fuentes"
                            4 => "C&#46; Mora-Fern&#225;ndez"
                            5 => "E&#46; Mart&#237;n-N&#250;&#241;ez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1155/2014/670475"
                      "Revista" => array:3 [
                        "tituloSerie" => "Mediators of Inflammation&#46;"
                        "fecha" => "2014"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18475648"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0375"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "1&#44;25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Y&#46;C&#46; Li"
                            1 => "J&#46; Kong"
                            2 => "M&#46; Wei"
                            3 => "Z&#46;F&#46; Chen"
                            4 => "S&#46;Q&#46; Liu"
                            5 => "L&#46;P&#46; Cao"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1172/JCI15219"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Invest&#46;"
                        "fecha" => "2002"
                        "volumen" => "110"
                        "paginaInicial" => "229"
                        "paginaFinal" => "238"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12122115"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0380"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Mizobuchi"
                            1 => "J&#46; Morrissey"
                            2 => "J&#46;L&#46; Finch"
                            3 => "D&#46;R&#46; Martin"
                            4 => "H&#46; Liapis"
                            5 => "T&#46; Akizawa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2006091028"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2007"
                        "volumen" => "18"
                        "paginaInicial" => "1796"
                        "paginaFinal" => "1806"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17513326"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0385"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "X&#46;X&#46; Wang"
                            1 => "T&#46; Jiang"
                            2 => "Y&#46; Shen"
                            3 => "H&#46; Santamaria"
                            4 => "H&#46; Santamaria"
                            5 => "N&#46; Solis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1152/ajprenal.00338.2010"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Physiol Renal Physiol&#46;"
                        "fecha" => "2011"
                        "volumen" => "300"
                        "paginaInicial" => "F801"
                        "paginaFinal" => "F810"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21209008"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0390"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Receptor agonists in the treatment of autoimmune diseases&#58; selective targeting of myeloid but not plasmacytoid dendritic cells"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "G&#46; Penna"
                            1 => "S&#46; Amuchastegui"
                            2 => "G&#46; Laverny"
                            3 => "L&#46; Adorini"
                            4 => "D&#46; Vitamin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Journal Of Bone And Mineral Research&#46;"
                        "fecha" => "2007"
                        "volumen" => "22"
                        "paginaInicial" => "69"
                        "paginaFinal" => "73"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0395"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "1&#44;25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Penna"
                            1 => "S&#46; Amuchastegui"
                            2 => "N&#46; Giarratana"
                            3 => "K&#46;C&#46; Daniel"
                            4 => "M&#46; Vulcano"
                            5 => "S&#46; Sozzani"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Immunol&#46;"
                        "fecha" => "2007"
                        "volumen" => "178"
                        "paginaInicial" => "145"
                        "paginaFinal" => "153"
                        "itemHostRev" => array:3 [
                          "pii" => "S1473309916301207"
                          "estado" => "S300"
                          "issn" => "14733099"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0400"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 Production"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Gonz&#225;lez-Mateo"
                            1 => "V&#46; Fern&#225;ndez-M&#237;llara"
                            2 => "T&#46; Bell&#243;n"
                            3 => "G&#46; Liappas"
                            4 => "M&#46; Ruiz-Ortega"
                            5 => "M&#46; L&#243;pez-Cabrera"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0108477"
                      "Revista" => array:5 [
                        "tituloSerie" => "Plos One&#46;"
                        "fecha" => "2014"
                        "volumen" => "9"
                        "paginaInicial" => "e108477"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25279459"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0405"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Switch from calcitriol to paricalcitol in secondary hyperparathyroidism of hemodialysis patients&#58; Responsiveness is related to parathyroid gland size"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Vulpio"
                            1 => "G&#46; Maresca"
                            2 => "E&#46; Distasio"
                            3 => "S&#46; Cacaci"
                            4 => "N&#46; Panocchia"
                            5 => "G&#46; Luciani"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1542-4758.2010.00514.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hemodial Int&#46;"
                        "fecha" => "2011"
                        "volumen" => "15"
                        "paginaInicial" => "69"
                        "paginaFinal" => "78"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21223484"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0410"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Low-dose cholecalciferol supplementation and dual vitamin D&#160;therapy&#160;in haemodialysis&#160;patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "N&#46; Mittman"
                            1 => "R&#46; Khana"
                            2 => "S&#46; Rani"
                            3 => "J&#46; Hor&#225;&#269;ek"
                            4 => "L&#46; Pavl&#237;kov&#225;"
                            5 => "V&#46; Pali&#269;ka"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Int Urol Nephrol&#46;"
                        "fecha" => "2015"
                        "volumen" => "47"
                        "paginaInicial" => "169"
                        "paginaFinal" => "176"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0415"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patient"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Capuano"
                            1 => "V&#46; Serio"
                            2 => "A&#46; Pota"
                            3 => "B&#46; Memoli"
                            4 => "V&#46;E&#46; Andreucci"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Nephrol&#46;"
                        "fecha" => "2009"
                        "volumen" => "22"
                        "paginaInicial" => "59"
                        "paginaFinal" => "68"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19229819"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0420"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Klotho&#46; An elixir of youth for the vasculature&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46; Shroff"
                            1 => "C&#46; Shanahan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Soc Nephrol"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "5"
                        "paginaFinal" => "7"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0425"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Soluble Klotho protects against uremic cardiomyopathy independently of Fibroblast Growth Factor 23 and phosphate"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46; Xie"
                            1 => "J&#46; Yoon"
                            2 => "S&#46;W&#46; An"
                            3 => "M&#46; Kuro"
                            4 => "M&#46; Kuro-o"
                            5 => "C&#46;L&#46; Huang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J AmSoc Nephrol&#46;"
                        "fecha" => "2015"
                        "volumen" => "26"
                        "paginaInicial" => "1150"
                        "paginaFinal" => "1160"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0430"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46; Xie"
                            1 => "S&#46;-K&#46; Cha"
                            2 => "S&#46;-W&#46; An"
                            3 => "M&#46; Kuro-O"
                            4 => "L&#46; Birnbaumer"
                            5 => "C&#46;L&#46; Huang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ncomms2240"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Commun&#46;"
                        "fecha" => "2012"
                        "volumen" => "3"
                        "paginaInicial" => "1238"
                        "paginaFinal" => "1259"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23212367"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0435"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Klotho depletion contributes to increased inflam-mation in kidney of the db&#47;db mouse model of diabetes via RelA &#40;serine&#41;536 phosphorylation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Zhao"
                            1 => "S&#46; Banerjee"
                            2 => "N&#46; Dey"
                            3 => "W&#46;S&#46; LeJeune"
                            4 => "P&#46;S&#46; Sarkar"
                            5 => "R&#46; Brobey"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Diabetes&#46;"
                        "fecha" => "2011"
                        "volumen" => "60"
                        "paginaInicial" => "1907"
                        "paginaFinal" => "1916"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0440"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The inflammatory cytokines TWEAK and TNF a reduce renal Klotho expression through NF-kB"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;A&#46; Moreno"
                            1 => "M&#46;C&#46; Izquierdo"
                            2 => "M&#46;D&#46; Sanchez-Ni&#241;o"
                            3 => "B&#46; Su&#225;rez-&#193;lvarez"
                            4 => "C&#46; L&#243;pez Larrea"
                            5 => "A&#46; Jakubowski"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2010101073"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "1315"
                        "paginaFinal" => "1325"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21719790"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0445"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The emerging role of Klotho in clinical nephrology"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "M&#46;C&#46; Hu"
                            1 => "M&#46; Kuro"
                            2 => "O&#46; Moe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfs160"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol Dial Transplant&#46;"
                        "fecha" => "2012"
                        "volumen" => "27"
                        "paginaInicial" => "2650"
                        "paginaFinal" => "2657"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22802580"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0450"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis&#58; results of the IMPACT SHPT study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Ketteler"
                            1 => "K&#46;J&#46; Martin"
                            2 => "M&#46; Wolf"
                            3 => "M&#46; Amdahl"
                            4 => "M&#46; Cozzolino"
                            5 => "D&#46; Goldsmith"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Nephrol Dial Transplant&#46;"
                        "fecha" => "2012"
                        "volumen" => "27"
                        "paginaInicial" => "3270"
                        "paginaFinal" => "3278"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib0455"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of cinacalcet and Vitamin D analogs on Fibroblast Growth Factor-23 during the treatment of secondary hyperparathyroidism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46;M&#46; Sprague"
                            1 => "J&#46;B&#46; Wetmore"
                            2 => "K&#46; Gurevich"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2215/CJN.03270314"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin J Am Soc Nephrol&#46;"
                        "fecha" => "2015"
                        "volumen" => "10"
                        "paginaInicial" => "1021"
                        "paginaFinal" => "1030"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25873267"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib0460"
              "etiqueta" => "40"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fibroblast Growth Factor 23 is not associated with and does not induce arterial calcification"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;J&#46; Scialla"
                            1 => "W&#46;L&#46; Lau"
                            2 => "M&#46;P&#46; Reilly"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.2013.3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2013"
                        "volumen" => "83"
                        "paginaInicial" => "1159"
                        "paginaFinal" => "1168"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23389416"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bib0465"
              "etiqueta" => "41"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Serum FGF 23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46; &#196;rnl&#246;v"
                            1 => "A&#46;C&#46; Carlsson"
                            2 => "J&#46; Sundstr&#246;m"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2215/CJN.09570912"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin J Am Soc Nephrol&#46;"
                        "fecha" => "2013"
                        "volumen" => "8"
                        "paginaInicial" => "781"
                        "paginaFinal" => "786"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23335040"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bib0470"
              "etiqueta" => "42"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fibroblast Growth Factor 23 is associated with proteinuria and smoking in chronic kidney disease&#58; an analysis of the MASTERPLAN cohort"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;G&#46; Vervloet"
                            1 => "A&#46;D&#46; van Zuilen"
                            2 => "P&#46;J&#46; Blankestijn"
                            3 => "P&#46;M&#46; ter Wee"
                            4 => "M&#46;L&#46; Bots"
                            5 => "P&#46;J&#46; Blankestijn"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Bio Med Central Nephrology&#46;"
                        "fecha" => "2012"
                        "volumen" => "24"
                        "paginaInicial" => "13"
                        "paginaFinal" => "20"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bib0475"
              "etiqueta" => "43"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "FGF 23 associates with death&#44; cardiovascular events&#44; and initiation of chronic dialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Kendrick"
                            1 => "A&#46;K&#46; Cheung"
                            2 => "J&#46;S&#46; Kaufman"
                            3 => "T&#46; Greene"
                            4 => "W&#46;L&#46; Roberts"
                            5 => "G&#46; Smits"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2010121224"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "1913"
                        "paginaFinal" => "1922"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21903574"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bib0480"
              "etiqueta" => "44"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hyperhomocysteinemia in end-stage renal disease&#58; prevalence&#44; etiology&#44; and potential relationship to arteriosclerotic outcomes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46;G&#46; Bostom"
                            1 => "L&#46; Lathrop"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.1997.298"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "1997"
                        "volumen" => "52"
                        "paginaInicial" => "10"
                        "paginaFinal" => "20"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9211341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bib0485"
              "etiqueta" => "45"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-inflammatory effects of short chain fatty acids in IFN-gammastimulated RAW 264&#46;7 murine macrophage cells&#58; involvement of NF-kappaB and ERK signaling pathways"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46;S&#46; Park"
                            1 => "E&#46;J&#46; Lee"
                            2 => "J&#46;C&#46; Lee"
                            3 => "W&#46;K&#46; Kim"
                            4 => "H&#46;S&#46; Kim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Int Immunopharmacol&#46;"
                        "fecha" => "2007"
                        "volumen" => "7"
                        "paginaInicial" => "70"
                        "paginaFinal" => "77"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bib0490"
              "etiqueta" => "46"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Association of high alpha2-Heremans-Schmid glycoprotein&#47;Fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;E&#46; Fiore"
                            1 => "G&#46; Celotta"
                            2 => "G&#46; Politi"
                            3 => "L&#46; di Pino"
                            4 => "Z&#46; Castelli"
                            5 => "R&#46;A&#46; Mangiafico"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.atherosclerosis.2006.08.052"
                      "Revista" => array:6 [
                        "tituloSerie" => "Atherosclerosis&#46;"
                        "fecha" => "2007"
                        "volumen" => "195"
                        "paginaInicial" => "110"
                        "paginaFinal" => "115"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17010978"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bib0495"
              "etiqueta" => "47"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46;J&#46; Lund"
                            1 => "M&#46; Davies"
                            2 => "A&#46; Brown"
                            3 => "K&#46;A&#46; Hruska"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/01.asn.0000109671.99498.08"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol"
                        "fecha" => "2004"
                        "volumen" => "15"
                        "paginaInicial" => "359"
                        "paginaFinal" => "369"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14747382"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bib0500"
              "etiqueta" => "48"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bone morphogenetic protein 7&#58; a novel treatment for chronic renal and bone disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "Li Tingting"
                            1 => "K&#46; Surendran"
                            2 => "M&#46; Zawaideh"
                            3 => "S&#46; Mathew"
                            4 => "K&#46;A&#46; Hruska"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0896860819893805"
                      "Revista" => array:6 [
                        "tituloSerie" => "Current Opinion in Nephrology &#38; Hypertension"
                        "fecha" => "2004"
                        "volumen" => "13"
                        "paginaInicial" => "417"
                        "paginaFinal" => "422"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32063210"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            48 => array:3 [
              "identificador" => "bib0505"
              "etiqueta" => "49"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bone morphogenetic protein-7 &#40;osteogenic protein-1&#41; inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "H&#46; Dorai"
                            1 => "S&#46; Vukicevic"
                            2 => "T&#46;K&#46; Sampath"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Cellular Physiol&#46;"
                        "fecha" => "2000"
                        "volumen" => "184"
                        "paginaInicial" => "37"
                        "paginaFinal" => "45"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            49 => array:3 [
              "identificador" => "bib0510"
              "etiqueta" => "50"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fibroblast growth factor signaling in the vasculature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "X&#46; Yang"
                            1 => "L&#46; Liaw"
                            2 => "I&#46; Prudovsky"
                            3 => "P&#46;C&#46; Brooks"
                            4 => "C&#46; Vary"
                            5 => "L&#46; Oxburgh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s11883-015-0509-6"
                      "Revista" => array:5 [
                        "tituloSerie" => "Curr Atheroscler Rep&#46;"
                        "fecha" => "2015"
                        "volumen" => "17"
                        "paginaInicial" => "509"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25813213"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            50 => array:3 [
              "identificador" => "bib0515"
              "etiqueta" => "51"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mesenchymal stem cells recruited by active TGFb contribute to osteogenic vascular calcification"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46; Wang"
                            1 => "C&#46; Li"
                            2 => "L&#46; Pang"
                            3 => "C&#46; Shi"
                            4 => "F&#46; Guo"
                            5 => "A&#46; Chen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1089/scd.2013.0528"
                      "Revista" => array:6 [
                        "tituloSerie" => "Stem Cells and Development&#46;"
                        "fecha" => "2014"
                        "volumen" => "23"
                        "paginaInicial" => "1392"
                        "paginaFinal" => "1404"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24512598"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            51 => array:3 [
              "identificador" => "bib0520"
              "etiqueta" => "52"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New insights into epithelial-mesenchymal transition in kidney fibrosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Y&#46; Liu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2008121226"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2010"
                        "volumen" => "21"
                        "paginaInicial" => "212"
                        "paginaFinal" => "222"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20019167"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02116995/0000004000000002/v1_202002280639/S0211699519301602/v1_202002280639/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "42448"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000004000000002/v1_202002280639/S0211699519301602/v1_202002280639/es/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699519301602?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Español
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 10 5 15
2024 Octubre 77 38 115
2024 Septiembre 54 24 78
2024 Agosto 68 60 128
2024 Julio 60 26 86
2024 Junio 69 48 117
2024 Mayo 66 32 98
2024 Abril 64 48 112
2024 Marzo 55 26 81
2024 Febrero 51 43 94
2024 Enero 36 28 64
2023 Diciembre 47 36 83
2023 Noviembre 79 32 111
2023 Octubre 36 38 74
2023 Septiembre 40 29 69
2023 Agosto 34 22 56
2023 Julio 52 32 84
2023 Junio 45 29 74
2023 Mayo 69 34 103
2023 Abril 40 22 62
2023 Marzo 59 20 79
2023 Febrero 40 27 67
2023 Enero 47 29 76
2022 Diciembre 74 35 109
2022 Noviembre 61 43 104
2022 Octubre 63 51 114
2022 Septiembre 69 38 107
2022 Agosto 50 60 110
2022 Julio 64 49 113
2022 Junio 76 50 126
2022 Mayo 76 47 123
2022 Abril 119 48 167
2022 Marzo 133 55 188
2022 Febrero 143 42 185
2022 Enero 130 51 181
2021 Diciembre 60 36 96
2021 Noviembre 86 43 129
2021 Octubre 48 60 108
2021 Septiembre 56 55 111
2021 Agosto 66 57 123
2021 Julio 48 58 106
2021 Junio 78 43 121
2021 Mayo 66 58 124
2021 Abril 86 82 168
2021 Marzo 58 52 110
2021 Febrero 50 26 76
2021 Enero 43 26 69
2020 Diciembre 27 19 46
2020 Noviembre 43 24 67
2020 Octubre 41 29 70
2020 Septiembre 71 48 119
2020 Agosto 45 35 80
2020 Julio 60 33 93
2020 Junio 62 56 118
2020 Mayo 156 68 224
2020 Abril 110 105 215
2020 Marzo 195 77 272
2020 Febrero 85 59 144
2020 Enero 101 31 132
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?